LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND

Abstract

A light-emitting device includes an organometallic compound represented by Formula 1, an electronic apparatus including the light-emitting device, and the organometallic compound represented by Formula 1 are provided:

##STR00001##

wherein substituents of Formula 1 are the same as described in the present specification.

Claims

1. A light-emitting device comprising: a first electrode; a second electrode facing the first electrode; an interlayer between the first electrode and the second electrode and comprising an emission layer; and an organometallic compound represented by Formula 1: ##STR00147## wherein, in Formula 1, M is platinum (Pt) or palladium (Pd), Y.sub.1 to Y.sub.4 are each independently a chemical bond, O, S, or Se, wherein the chemical bond is a covalent bond or a coordinate bond, X.sub.1 to X.sub.4 are each independently C or N, ring CY.sub.1 to ring CY.sub.4 are each independently a C.sub.5-C.sub.30 carbocyclic group or a C.sub.1-C.sub.30 heterocyclic group, at least one of ring CY.sub.1 to ring CY.sub.4 comprises a 5-membered ring, L.sub.1 to L.sub.3 are each independently a single bond, *—C(R.sub.1a)(R.sub.1b)—*′, *—C(R.sub.1a)═*′, *′C(R.sub.1a)—*′, *—C(R.sub.1a)═C(R.sub.1b)—*′, *—C(═O)—*′, *—C(═S)—*′, *—C≡C*′, *—B(R.sub.1a)—*′, *—N(R.sub.1a)—*′, *—O—*′, *—P(R.sub.1a)—*′, *—Si(R.sub.1a)(R.sub.1b)—*′, *—P(═O)(R.sub.1a)—*′, *—S(═O)—*′, *—S(═O).sub.2-*′, *—Ge(R.sub.1a)(R.sub.1b)—*′, *—Se—*′, a C.sub.3-C.sub.30 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.30 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, or any combination thereof, wherein * and *′ each indicate a binding site to a neighboring atom, n1 to n3 are each independently an integer from 1 to 10, R.sub.1 to R.sub.4, R.sub.1a, and R.sub.1b are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group unsubstituted or substituted with at least one R.sub.10a, —C(Q.sub.1)(Q.sub.2)(Q.sub.3), —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —N(Q.sub.1)(Q.sub.2), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2), a1 to a4 are each independently an integer from 0 to 10, R.sub.10a is: deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group; a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, —Si(Q.sub.11)(Q.sub.12)(Q.sub.13), —N(Q.sub.11)(Q.sub.12), —B(Q.sub.11)(Q.sub.12), —C(═O)(Q.sub.11), —S(═O).sub.2(Q.sub.11), —P(═O)(Q.sub.11)(Q.sub.12), or any combination thereof; a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, or a C.sub.6-C.sub.60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, —Si(Q.sub.21)(Q.sub.22)(Q.sub.23), —N(Q.sub.21)(Q.sub.22), —B(Q.sub.21)(Q.sub.22), —C(═O)(Q.sub.21), —S(═O).sub.2(Q.sub.21), —P(═O)(Q.sub.21)(Q.sub.22), or any combination thereof; or —Si(Q.sub.31)(Q.sub.32)(Q.sub.33), —N(Q.sub.31)(Q.sub.32), —B(Q.sub.31)(Q.sub.32), —C(═O)(Q.sub.31), —S(═O).sub.2(Q.sub.31), or —P(═O)(Q.sub.31)(Q.sub.32), Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, —F, a cyano group, or any combination thereof; a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof; a C.sub.7-C.sub.60 arylalkyl group; or a C.sub.2-C.sub.60 heteroarylalkyl group, and the organometallic compound represented by Formula 1 satisfies at least one of <Condition 1-1>to <Condition 1-5>: <Condition 1-1> at least one selected from the group consisting of Y.sub.1 and Y.sub.4 is not a chemical bond, and L.sub.2 is not a single bond; <Condition 1-2> Y.sub.2 is not a chemical bond, and L.sub.1 is not a single bond; <Condition 1-3> Y.sub.2 is not a chemical bond, and L.sub.2 is not a single bond; <Condition 1-4> Y.sub.3 is not a chemical bond, and L.sub.2 is not a single bond; and <Condition 1-5> Y.sub.3 is not a chemical bond, and L.sub.3 is not a single bond.

2. The light-emitting device of claim 1, wherein the first electrode is an anode, the second electrode is a cathode, the interlayer further comprises a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode, the hole transport region comprises a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and the electron transport region comprises a hole blocking layer, an electron transport layer, an electron injection layer, an electron control layer, or any combination thereof.

3. The light-emitting device of claim 1, wherein the emission layer comprises the organometallic compound represented by Formula 1.

4. The light-emitting device of claim 1, wherein the emission layer comprises a host and a dopant, and the dopant comprises the organometallic compound represented by Formula 1.

5. The light-emitting device of claim 1, wherein the organometallic compound represented by Formula 1 has a triplet metal-to-ligand charge transfer (.sup.3MLCT) value of 20% or more.

6. An electronic apparatus comprising the light-emitting device of claim 1.

7. The electronic apparatus of claim 6, further comprising a thin-film transistor, wherein the thin-film transistor comprises a source electrode and a drain electrode, and the first electrode of the light-emitting device is electrically connected to the source electrode or the drain electrode of the thin-film transistor.

8. The electronic apparatus of claim 6, further comprising a color filter, a color conversion layer, a touch screen layer, a polarizing layer, or any combination thereof.

9. An organometallic compound represented by Formula 1: ##STR00148## wherein, in Formula 1, M is platinum (Pt) or palladium (Pd), Y.sub.1 to Y.sub.4 are each independently a chemical bond, O, S, or Se, wherein the chemical bond is a covalent bond or a coordinate bond, X.sub.1 to X.sub.4 are each independently C or N, ring CY.sub.1 to ring CY.sub.4 are each independently a C.sub.5-C.sub.30 carbocyclic group or a C.sub.1-C.sub.30 heterocyclic group, at least one of ring CY.sub.1 to ring CY.sub.4 comprises a 5-membered ring, L.sub.1 to L.sub.3 are each independently a single bond, *—C(R.sub.1a)(R.sub.1b)—*′, *—C(R.sub.1a)═*′, *═C(R.sub.1a)—*′, *—C(R.sub.1a)═C(R.sub.1b)—*′, *—C(═O)—*′, *—C(═S)—*′, *—C≡*′, *—B(R.sub.1a)—*′, *—N(R.sub.1a)—*′, *—O—*′, *—P(R.sub.1a)—*′, *—Si(R.sub.1a)(R.sub.1b)—*′, *—P(═O)(R.sub.1a)—*′, *—S—*′, *—S(═O)—*′, *—S(═O).sub.2-*′, *—Ge(R.sub.1a)(R.sub.1b)—*′, *—Se—*′, a C.sub.3-C.sub.30 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.30 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, or any combination thereof, wherein * and *′ each indicate a binding site to a neighboring atom, n1 to n3 are each independently an integer from 1 to 10, R.sub.1 to R.sub.4, R.sub.1a, and R.sub.1b are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group unsubstituted or substituted with at least one R.sub.10a, —C(Q.sub.1)(Q.sub.2)(Q.sub.3), —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —N(Q.sub.1)(Q.sub.2), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2), a1 to a4 are each independently an integer from 0 to 10, R.sub.10a is: deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group; a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, —Si(Q.sub.11)(Q.sub.12)(Q.sub.13), —N(Q.sub.11)(Q.sub.12), —B(Q.sub.11)(Q.sub.12), —C(═O)(Q.sub.11), —S(═O).sub.2(Q.sub.11), —P(═O)(Q.sub.11)(Q.sub.12), or any combination thereof; a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, or a C.sub.6-C.sub.60 arylthio group, each unsubstituted or substituted with deuterium, —F, -Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, —Si(Q.sub.21)(Q.sub.22)(Q.sub.23), —N(Q.sub.21)(Q.sub.22), —B(Q.sub.21)(Q.sub.22), —C(═O)(Q.sub.21), —S(═O).sub.2(Q.sub.21), —P(═O)(Q.sub.21)(Q.sub.22), or any combination thereof; or —Si(Q.sub.31)(Q.sub.32)(Q.sub.33), —N(Q.sub.31)(Q.sub.32), —B(Q.sub.31)(Q.sub.32), —C(═O)(Q.sub.31), —S(═O).sub.2(Q.sub.31), or —P(═O)(Q.sub.31)(Q.sub.32), Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, —F, a cyano group, or any combination thereof; a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof; a C.sub.7-C.sub.60 arylalkyl group; or a C.sub.2-C.sub.60 heteroarylalkyl group, and the organometallic compound represented by Formula 1 satisfies at least one of <Condition 1-1>to <Condition 1-5>: <Condition 1-1> at least one selected from the group consisting of Y.sub.1 and Y.sub.4 is not a chemical bond, and L.sub.2 is not a single bond; <Condition 1-2> Y.sub.2 is not a chemical bond, and L.sub.1 is not a single bond; <Condition 1-3> Y.sub.2 is not a chemical bond, and L.sub.2 is not a single bond; <Condition 1-4> Y.sub.3 is not a chemical bond, and L.sub.2 is not a single bond; and <Condition 1-5> Y.sub.3 is not a chemical bond, and L.sub.3 is not a single bond.

10. The organometallic compound of claim 9, wherein i) Y.sub.1 is O, S, or Se, and Y.sub.2 to Y.sub.4 are each a chemical bond, ii) Y.sub.2 is O, S, or Se, and Y.sub.1, Y.sub.3, and Y.sub.4 are each a chemical bond, iii) Y.sub.3 is O, S, or Se, and Y.sub.1, Y.sub.2, and Y.sub.4 are each a chemical bond, or iv) Y.sub.4 is O, S, or Se, and Y.sub.1 to Y.sub.3 are each a chemical bond.

11. The organometallic compound of claim 9, wherein i) when Y.sub.1 is O, S, or Se, X.sub.1 is C, ii) when Y.sub.2 is O, S, or Se, X.sub.2 is C, iii) when Y.sub.3 is O, S, or Se, X.sub.3 is C, and iv) when Y.sub.4 is O, S, or Se, X.sub.4 is C.

12. The organometallic compound of claim 9, wherein two selected from ring CY.sub.1 to ring CY.sub.4 are each independently a C.sub.5-C.sub.30 carbocyclic group, and a remaining two of ring CY.sub.1 to ring CY.sub.4 are each independently a C.sub.1-C.sub.30 heterocyclic group.

13. The organometallic compound of claim 9, wherein ring CY.sub.1 to ring CY.sub.4 are each independently a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, an indole group, a benzoborole group, a benzophosphole group, an indene group, a benzosilole group, a benzogermole group, a benzothiophene group, a benzoselenophene group, a benzofuran group, a carbazole group, a dibenzoborole group, a dibenzophosphole group, a fluorene group, a dibenzosilole group, a dibenzogermole group, a dibenzothiophene group, a dibenzoselenophene group, a dibenzofuran group, a dibenzothiophene 5-oxide group, a 9H-fluorene-9-one group, a dibenzothiophene 5,5-dioxide group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, or a benzothiadiazole group.

14. The organometallic compound of claim 9, wherein moieties represented by ##STR00149## in Formula 1 are each independently a group represented by one of Formulae CY(1)-1 to CY(1)-18: ##STR00150## ##STR00151## ##STR00152## wherein, in Formulae CY(1)-1 to CY(1)-18, X.sub.11 is C or N, Z.sub.1 is O, S, or Se, Z.sub.2 is O, S, Se, N(R.sub.11a), C(R.sub.11a)(R.sub.11b), or Si(R.sub.11a)(R.sub.11b), R.sub.11, R.sub.12, R.sub.11a, and R.sub.11b are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group unsubstituted or substituted with at least one R.sub.10a, —C(Q.sub.1)(Q.sub.2)(Q.sub.3), —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —N(Q.sub.1)(Q.sub.2), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2), b11 is an integer from 0 to 4, b12 is an integer from 0 to 6, b13 is an integer from 0 to 2, b14 is an integer from 0 to 3, * and *′ each indicate a binding site to a neighboring atom, and R.sub.10a and Q.sub.1 to Q.sub.3 are respectively the same as described in connection with Formula 1.

15. The organometallic compound of claim 9, wherein moieties represented by ##STR00153## in Formula 1 are each independently a group represented by one of Formulae CY(2)-1 to CY(2)-18: ##STR00154## ##STR00155## ##STR00156## wherein, in Formulae CY(2)-1 to CY(2)-18, X.sub.12 is C or N, Z.sub.3 is O, S, or Se, Z.sub.4 is O, S, Se, N(R.sub.21a), C(R.sub.21a)(R.sub.21b), or Si(R.sub.21a)(R.sub.21b), R.sub.21, R.sub.22, R.sub.21a, and R.sub.21b are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group unsubstituted or substituted with at least one R.sub.10a, —C(Q.sub.1)(Q.sub.2)(Q.sub.3), —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —N(Q.sub.1)(Q.sub.2), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2), b21 is an integer from 0 to 3, b22 is an integer from 0 to 5, b23 is 0 or 1, b24 is an integer from 0 to 4, b25 is an integer from 0 to 2, *, *′, and *″ each indicate a binding site to a neighboring atom, and R.sub.10a and Q.sub.1 to Q.sub.3 are respectively the same as described in connection with Formula 1.

16. The organometallic compound of claim 9, wherein *-(L.sub.1).sub.n1-*′, *-(L.sub.2).sub.n2-*′, and *-(L.sub.3).sub.n3-*′ in Formula 1 are each independently a single bond, at least one of the groups represented by Formulae L-1 to L-32, or any combination thereof: ##STR00157## ##STR00158## ##STR00159## wherein, * and *′ in Formulae L-1 to L-32 each indicate a binding site to a neighboring atom.

17. The organometallic compound of claim 9, wherein R.sub.1 to R.sub.4 are each independently hydrogen, deuterium, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroaryl group unsubstituted or substituted with at least one R.sub.10a, a monovalent non-aromatic condensed polycyclic group unsubstituted or substituted with at least one R.sub.10a, or a monovalent non-aromatic condensed heteropolycyclic group unsubstituted or substituted with at least one R.sub.10a, and R.sub.10a is the same described in connection with Formula 1.

18. The organometallic compound of claim 9, wherein, when at least one of ring CY.sub.1 to ring CY.sub.4 comprises a 5-membered ring, at least one of the 5-membered rings is bonded to M in Formula 1 via one of Y.sub.1 to Y.sub.4.

19. The organometallic compound of claim 9, wherein the organometallic compound has a triplet metal-to-ligand charge transfer (.sup.3MLCT) value of 20% or more.

20. The organometallic compound of claim 9, wherein the organometallic compound is one of Compounds D1 to D67: ##STR00160## ##STR00161## ##STR00162## ##STR00163## ##STR00164## ##STR00165## ##STR00166## ##STR00167## ##STR00168## ##STR00169## ##STR00170## ##STR00171## ##STR00172## ##STR00173## ##STR00174## ##STR00175## ##STR00176## ##STR00177## ##STR00178## ##STR00179##

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0038] The above and other aspects, features, and enhancements of certain embodiments of the disclosure will be more apparent from the following description taken in conjunction with the accompanying drawings, in which:

[0039] FIG. 1 is a schematic cross-sectional view of a light-emitting device according to an embodiment;

[0040] FIG. 2 is a schematic cross-sectional view of an electronic apparatus according to an embodiment; and

[0041] FIG. 3 is a schematic cross-sectional view of an electronic apparatus according to another embodiment.

DETAILED DESCRIPTION

[0042] Reference will now be made in more detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout, and duplicative descriptions thereof may not be provided. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the drawings, to explain aspects of the present description. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items. Throughout the disclosure, the expression “at least one of a, b or c”, “at least one selected from a, b, and c”, “at least one selected from the group consisting of a, b, and c”, etc., indicates only a, only b, only c, both (e.g., simultaneously) a and b, both (e.g., simultaneously) a and c, both (e.g., simultaneously) b and c, all of a, b, and c, or variations thereof.

[0043] A light-emitting device according to an embodiment of the present disclosure may include: a first electrode; a second electrode facing the first electrode; an interlayer located between the first electrode and the second electrode and including an emission layer; and an organometallic compound represented by Formula 1:

##STR00003##

[0044] wherein, in Formula 1, M may be platinum (Pt) or palladium (Pd).

[0045] Y.sub.1 to Y.sub.4 in Formula 1 may each independently be a chemical bond, O, S, or Se, wherein the chemical bond may be a covalent bond or a coordinate bond.

[0046] In an embodiment, i) Y.sub.1 may be O, S, or Se, and Y.sub.2 to Y.sub.4 may each be a chemical bond, ii) Y.sub.2 may be O, S, or Se, and Y.sub.1, Y.sub.3, and Y.sub.4 may each be a chemical bond, iii) Y.sub.3 may be O, S, or Se, and Y.sub.1, Y.sub.2, and Y.sub.4 may each be a chemical bond, or iv) Y.sub.4 may be O, S, or Se, and Y.sub.1 to Y.sub.3 may each be a chemical bond.

[0047] X.sub.1 to X.sub.4 in Formula 1 may each independently be C or N.

[0048] In an embodiment, i) when Y.sub.1 is O, S, or Se, X.sub.1 may be C, ii) when Y.sub.2 is O, S, or Se, X.sub.2 may be C, iii) when Y.sub.3 is O, S, or Se, X.sub.3 may be C, and iv) when Y.sub.4 is O, S, or Se, X.sub.4 may be C.

[0049] Ring CY.sub.1 to ring CY.sub.4 in Formula 1 may each independently be a C.sub.5-C.sub.30 carbocyclic group or a C.sub.1-C.sub.30 heterocyclic group.

[0050] In an embodiment, at least one of ring CY.sub.1 to ring CY.sub.4 may include a 5-membered ring.

[0051] In an embodiment, when at least one of (e.g., at least one selected from the group consisting of) ring CY.sub.1 to ring CY.sub.4 includes a 5-membered ring, at least one of the 5-membered rings may be bonded to M in Formula 1 via one of Y.sub.1 to Y.sub.4.

[0052] For example, when ring CY.sub.1 includes a 5-membered ring, the 5-membered ring may be bonded to M in Formula 1 via Y.sub.1, and the 5-membered ring may be bonded to ring CY2 via L.sub.1. For example, when ring CY2 includes a 5-membered ring, the 5-membered ring may be bonded to M in Formula 1 via Y.sub.2, the 5-membered ring may be bonded to ring CY.sub.1 via L.sub.1, and the 5-membered ring may be bonded to ring CY.sub.3 via L.sub.2. For example, when ring CY.sub.3 includes a 5-membered ring, the 5-membered ring may be bonded to M in Formula 1 via Y.sub.3, the 5-membered ring may be bonded to ring CY2 via L.sub.2, and the 5-membered ring may be bonded to ring CY.sub.4 via L.sub.3. For example, when ring CY.sub.4 includes a 5-membered ring, the 5-membered ring may be bonded to M in Formula 1 via Y.sub.4, and the 5-membered ring may be bonded to ring CY.sub.3 via L.sub.3.

[0053] In an embodiment, when at least one of ring CY.sub.1 to ring CY.sub.4 includes a 5-membered ring, the 5-membered ring may include at least one nitrogen. For example, the 5-membered ring may include one nitrogen, and may optionally further include nitrogen (e.g., a second nitrogen), oxygen (O), and/or sulfur (S).

[0054] In an embodiment, at least two of ring CY.sub.1 to ring CY.sub.4 may each independently be a C.sub.1-C.sub.30 heterocyclic group.

[0055] In an embodiment, two of ring CY.sub.1 to ring CY.sub.4 may each independently be a C.sub.5-C.sub.30 carbocyclic group, and the remaining two of ring CY.sub.1 to ring CY.sub.4 may each independently be a C.sub.1-C.sub.30 heterocyclic group. In this regard, at least one of the C.sub.1-C.sub.30 heterocyclic groups may be a 5-membered ring.

[0056] For example, ring CY.sub.1 to ring CY.sub.4 may each independently be a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentadiene group, a 1,2,3,4-tetrahydronaphthalene group, a thiophene group, a furan group, an indole group, a benzoborole group, a benzophosphole group, an indene group, a benzosilole group, a benzogermole group, a benzothiophene group, a benzoselenophene group, a benzofuran group, a carbazole group, a dibenzoborole group, a dibenzophosphole group, a fluorene group, a dibenzosilole group, a dibenzogermole group, a dibenzothiophene group, a dibenzoselenophene group, a dibenzofuran group, a dibenzothiophene 5-oxide group, a 9H-fluorene-9-one group, a dibenzothiophene 5,5-dioxide group, an azaindole group, an azabenzoborole group, an azabenzophosphole group, an azaindene group, an azabenzosilole group, an azabenzogermole group, an azabenzothiophene group, an azabenzoselenophene group, an azabenzofuran group, an azacarbazole group, an azadibenzoborole group, an azadibenzophosphole group, an azafluorene group, an azadibenzosilole group, an azadibenzogermole group, an azadibenzothiophene group, an azadibenzoselenophene group, an azadibenzofuran group, an azadibenzothiophene 5-oxide group, an aza-9H-fluorene-9-one group, an azadibenzothiophene 5,5-dioxide group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, a benzothiadiazole group, a 5,6,7,8-tetrahydroisoquinoline group, or a 5,6,7,8-tetrahydroquinoline group.

[0057] In an embodiment, ring CY.sub.1 to ring CY.sub.4 may each independently be a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, an indole group, a benzoborole group, a benzophosphole group, an indene group, a benzosilole group, a benzogermole group, a benzothiophene group, a benzoselenophene group, a benzofuran group, a carbazole group, a dibenzoborole group, a dibenzophosphole group, a fluorene group, a dibenzosilole group, a dibenzogermole group, a dibenzothiophene group, a dibenzoselenophene group, a dibenzofuran group, a dibenzothiophene 5-oxide group, a 9H-fluorene-9-one group, a dibenzothiophene 5,5-dioxide group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, or a benzothiadiazole group.

[0058] In an embodiment, moieties represented by

##STR00004##

in Formula 1 may each independently be one of the groups represented by Formulae CY(1)-1 to CY(1)-18:

##STR00005## ##STR00006## ##STR00007##

[0059] wherein, in Formulae CY(1)-1 to CY(1)-18,

[0060] X.sub.11 may be C or N,

[0061] Z.sub.1 may be O, S, or Se,

[0062] Z.sub.2 may be O, S, Se, N(R.sub.11a), C(R.sub.11a)(R.sub.11b), or Si(R.sub.11a)(R.sub.11b),

[0063] R.sub.11, R.sub.12, R.sub.11a, and R.sub.11b may each independently be hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group unsubstituted or substituted with at least one R.sub.10a, —C(Q.sub.1)(Q.sub.2)(Q.sub.3), —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —N(Q.sub.1)(Q.sub.2), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2),

[0064] b11 may be an integer from 0 to 4,

[0065] b12 may be an integer from 0 to 6,

[0066] b13 may be an integer from 0 to 2,

[0067] b14 may be an integer from 0 to 3,

[0068] * and *′ each indicate a binding site to a neighboring atom, and

[0069] R.sub.10a and Q.sub.1 to Q.sub.3 are respectively the same as described herein.

[0070] In an embodiment, R.sub.11, R.sub.12, R.sub.11a, and R.sub.11b may each independently be hydrogen, deuterium, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroaryl group unsubstituted or substituted with at least one R.sub.10a, a monovalent non-aromatic condensed polycyclic group unsubstituted or substituted with at least one R.sub.10a, or a monovalent non-aromatic condensed heteropolycyclic group unsubstituted or substituted with at least one R.sub.10a. R.sub.10a is the same as described herein.

[0071] In an embodiment, R.sub.11, R.sub.12, R.sub.11a, and R.sub.11b may each independently be:

[0072] hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, or a C.sub.1-C.sub.20 alkylthio group;

[0073] a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, or a C.sub.1-C.sub.20 alkylthio group, each substituted with deuterium, —F, —Cl, —Br, —I, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CF.sub.3, —CF.sub.2H, —CFH.sub.2, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.10 alkyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, or any combination thereof;

[0074] a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.10 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzoisothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azafluorenyl group, or an azadibenzosilolyl group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CF.sub.3, —CF.sub.2H, —CFH.sub.2, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, a C.sub.1-C.sub.20 alkylthio group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.10 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzoisothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azafluorenyl group, an azadibenzosilolyl group, —Si(Q.sub.31)(Q.sub.32)(Q.sub.33), —B(Q.sub.31)(Q.sub.32), —P(Q.sub.31)(Q.sub.32), —C(═O)(Q.sub.31), —S(═O).sub.2(Q.sub.31), —P(═O)(Q.sub.31)(Q.sub.32), or any combination thereof; or

[0075] —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2), and

[0076] Q.sub.1 to Q.sub.3 and Q.sub.31 to Q.sub.33 may each independently be: —CH.sub.3, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CH.sub.2CH.sub.3, —CH.sub.2CD.sub.3, —CH.sub.2CD.sub.2H, —CH.sub.2CDH.sub.2, —CHDCH.sub.3, —CHDCD.sub.2H, —CHDCDH.sub.2, —CHDCD.sub.3, —CD.sub.2CD.sub.3, —CD.sub.2CD.sub.2H, or —CD.sub.2CDH.sub.2; or

[0077] an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, or a triazinyl group, each unsubstituted or substituted with at least one of deuterium, a C.sub.1-C.sub.10 alkyl group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, or a triazinyl group.

[0078] In an embodiment, moieties represented by

##STR00008##

in Formula 1 may each independently be one of the groups represented by Formulae CY(2)-1 to CY(2)-18:

##STR00009## ##STR00010## ##STR00011##

[0079] wherein, in Formulae CY(2)-1 to CY(2)-18,

[0080] X.sub.12 may be C or N,

[0081] Z.sub.3 may be O, S, or Se,

[0082] Z.sub.4 may be O, S, Se, N(R.sub.21a), C(R.sub.21a)(R.sub.21b), or Si(R.sub.21a)(R.sub.21b),

[0083] R.sub.21, R.sub.22, R.sub.21a, and R.sub.21b may each independently be hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group unsubstituted or substituted with at least one R.sub.10a, —C(Q.sub.1)(Q.sub.2)(Q.sub.3), —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —N(Q.sub.1)(Q.sub.2), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2),

[0084] b21 may be an integer from 0 to 3,

[0085] b22 may be an integer from 0 to 5,

[0086] b23 may be 0 or 1,

[0087] b24 may be an integer from 0 to 4,

[0088] b25 may be an integer from 0 to 2,

[0089] *, *′, and *″ each indicate a binding site to a neighboring atom, and

[0090] R.sub.10a and Q.sub.1 to Q.sub.3 are respectively the same as described herein.

[0091] In an embodiment, R.sub.21, R.sub.22, R.sub.21a, and R.sub.21b may each independently be hydrogen, deuterium, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroaryl group unsubstituted or substituted with at least one R.sub.10a, a monovalent non-aromatic condensed polycyclic group unsubstituted or substituted with at least one R.sub.10a, or a monovalent non-aromatic condensed heteropolycyclic group unsubstituted or substituted with at least one R.sub.10a. R.sub.10a is the same as described herein.

[0092] In an embodiment, R.sub.21, R.sub.22, R.sub.21a, and R.sub.21b each independently be: hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, or a C.sub.1-C.sub.20 alkylthio group;

[0093] a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, or a C.sub.1-C.sub.20 alkylthio group, each substituted with deuterium, —F, —Cl, —Br, —I, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CF.sub.3, —CF.sub.2H, —CFH.sub.2, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.10 alkyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, or any combination thereof;

[0094] a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.10 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzoisothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azafluorenyl group, or an azadibenzosilolyl group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CF.sub.3, —CF.sub.2H, —CFH.sub.2, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, a C.sub.1-C.sub.20 alkylthio group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.10 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzoisothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azafluorenyl group, an azadibenzosilolyl group, —Si(Q.sub.31)(Q.sub.32)(Q.sub.33), —B(Q.sub.31)(Q.sub.32), —P(Q.sub.31)(Q.sub.32), —C(═O)(Q.sub.31), —S(═O).sub.2(Q.sub.31), —P(═O)(Q.sub.31)(Q.sub.32), or any combination thereof; or

[0095] —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2), and

[0096] Q.sub.1 to Q.sub.3 and Q.sub.31 to Q.sub.33 may each independently be: —CH.sub.3, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CH.sub.2CH.sub.3, —CH.sub.2CD.sub.3, —CH.sub.2CD.sub.2H, —CH.sub.2CDH.sub.2, —CHDCH.sub.3, —CHDCD.sub.2H, —CHDCDH.sub.2, —CHDCD.sub.3, —CD.sub.2CD.sub.3, —CD.sub.2CD.sub.2H, or —CD.sub.2CDH.sub.2; or

[0097] an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, or a triazinyl group, each unsubstituted or substituted with at least one of deuterium, a C.sub.1-C.sub.10 alkyl group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, and a triazinyl group.

[0098] L.sub.1 to L.sub.3 in Formula 1 may each independently be a single bond, *—C(R.sub.1a)(R.sub.1b)—*′, *—C(R.sub.1a)═*′, *′C(R.sub.1a)—*′, *—C(R.sub.1a)═C(R.sub.1b)—*′, *—C(═O)—*′, *—C(═S)—*′, *—C≡C—*′, *—B(R.sub.1a)—*′, *—N(R.sub.1a)—*′, *—O—*′, *—P(R.sub.1a)—*′, *—Si(R.sub.1a)(R.sub.1b)—*′, *—P(═O)(R.sub.1a)—*′, *—S(═O)—*′, *—S(═O).sub.2—*′, *—Ge(R.sub.1a)(R.sub.1b)—*′, *—Se—*′, a C.sub.3-C.sub.30 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.30 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, or any combination thereof (e.g., the any combination being selected from L.sub.1, L.sub.2, and L.sub.3, each of L.sub.1, L.sub.2, and L.sub.3 independently being one of the above disclosed single bond or groups). * and *′ each indicate a binding site to a neighboring atom. R.sub.1a and R.sub.1b are respectively the same as respectively described herein.

[0099] In an embodiment, L.sub.1 to L.sub.3 may each independently be a single bond, *—C(R.sub.1a)(R.sub.1b)—*′, *—C(R.sub.1a)═*′, *′C(R.sub.1a)—*′, *—C(R.sub.1a)═C(R.sub.1b)—*′, *—C≡C—*′, *—Se—*′, a C.sub.1-C.sub.30 arylene group unsubstituted or substituted with at least one R.sub.10a, or any combination thereof.

[0100] For example, L.sub.1 to L.sub.3 may each independently be a single bond, *—C(R.sub.1a)(R.sub.1b)—*′, *—C(R.sub.1a)═*′, *′C(R.sub.1a)—*′, *—C(R.sub.1a)═C(R.sub.1b)—*′, *—C≡C—*′, *—Se—*′, a phenylene group, a naphthylene group, a phenanthrenylene group, an anthracenylene group, a pyrenylene group, a chrysenylene group, or any combination thereof.

[0101] n1 to n4 in Formula 1 may each independently be an integer from 1 to 10.

[0102] In an embodiment, *-(L.sub.1).sub.n1-*′, *-(L.sub.2).sub.n2-*′, and *-(L.sub.3).sub.n3—*′ in Formula 1 may each independently be a single bond, at least one of the groups represented by Formulae L-1 to L-32, or any combination thereof:

##STR00012## ##STR00013## ##STR00014##

[0103] * and *′ in the groups represented by Formulae L-1 to L-32 each indicate a binding site to a neighboring atom.

[0104] R.sub.1 to R.sub.4, R.sub.1a, and R.sub.1b in Formula 1 may each independently be hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group unsubstituted or substituted with at least one R.sub.10a, —C(Q.sub.1)(Q.sub.2)(Q.sub.3), —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —N(Q.sub.1)(Q.sub.2), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2). R.sub.10a and Q.sub.1 to Q.sub.3 are respectively the same as described herein.

[0105] In an embodiment, R.sub.1 to R.sub.4, R.sub.1a, and R.sub.1b may each independently be:

[0106] hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, or a C.sub.1-C.sub.20 alkylthio group;

[0107] a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, or a C.sub.1-C.sub.20 alkylthio group, each substituted with deuterium, —F, —Cl, —Br, —I, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CF.sub.3, —CF.sub.2H, —CFH.sub.2, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.10 alkyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, or any combination thereof;

[0108] a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.10 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzoisothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azafluorenyl group, or an azadibenzosilolyl group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CF.sub.3, —CF.sub.2H, —CFH.sub.2, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, a C.sub.1-C.sub.20 alkylthio group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.10 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzoisothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azafluorenyl group, an azadibenzosilolyl group, —Si(Q.sub.31)(Q.sub.32)(Q.sub.33), —B(Q.sub.31)(Q.sub.32), —P(Q.sub.31)(Q.sub.32), —C(═O)(Q.sub.31), —S(═O).sub.2(Q.sub.31), —P(═O)(Q.sub.31)(Q.sub.32), or any combination thereof; or

[0109] —Si(Q.sub.1)(Q.sub.2)(Q.sub.3), —B(Q.sub.1)(Q.sub.2), —C(═O)(Q.sub.1), —S(═O).sub.2(Q.sub.1), or —P(═O)(Q.sub.1)(Q.sub.2), and

[0110] Q.sub.1 to Q.sub.3 and Q.sub.31 to Q.sub.33 may each independently be: —CH.sub.3, —CD.sub.3, —CD.sub.2H, —CDH.sub.2, —CH.sub.2CH.sub.3, —CH.sub.2CD.sub.3, —CH.sub.2CD.sub.2H, —CH.sub.2CDH.sub.2, —CHDCH.sub.3, —CHDCD.sub.2H, —CHDCDH.sub.2, —CHDCD.sub.3, —CD.sub.2CD.sub.3, —CD.sub.2CD.sub.2H, or —CD.sub.2CDH.sub.2; or

[0111] an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, or a triazinyl group, each unsubstituted or substituted with at least one of deuterium, a C.sub.1-C.sub.10 alkyl group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, or a triazinyl group.

[0112] In an embodiment, R.sub.1 to R.sub.4 may each independently be hydrogen, deuterium, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroaryl group unsubstituted or substituted with at least one R.sub.10a, a monovalent non-aromatic condensed polycyclic group unsubstituted or substituted with at least one R.sub.10a, or a monovalent non-aromatic condensed heteropolycyclic group unsubstituted or substituted with at least one R.sub.10a. R.sub.10a is the same as described herein.

[0113] In an embodiment, R.sub.1 to R.sub.4 may each independently be: hydrogen or deuterium;

[0114] a C.sub.1-C.sub.10 alkyl group unsubstituted or substituted with deuterium, a phenyl group, or any combination thereof; or

[0115] a phenyl group or a naphthyl group, each unsubstituted or substituted with deuterium, a C.sub.1-C.sub.10 alkyl group, a phenyl group, or any combination thereof.

[0116] a1 to a4 in Formula 1 may each independently be an integer from 0 to 10.

[0117] The organometallic compound represented by Formula 1 may satisfy at least one of <Condition 1-1>to <Condition 1-5>: [0118] <Condition 1-1>

[0119] at least one of Y.sub.1 or Y.sub.4 is not a chemical bond, and L.sub.2 is not a single bond; [0120] <Condition 1-2>

[0121] Y.sub.2 is not a chemical bond, and L.sub.1 is not a single bond; [0122] <Condition 1-3>

[0123] Y.sub.2 is not a chemical bond, and L.sub.2 is not a single bond; [0124] <Condition 1-4>

[0125] Y.sub.3 is not a chemical bond, and L.sub.2 is not a single bond; and [0126] <Condition 1-5>

[0127] Y.sub.3 is not a chemical bond, and L.sub.3 is not a single bond.

[0128] In an embodiment, the organometallic compound may satisfy one of <Condition 1-1>to <Condition 1-5>.

[0129] In one or more embodiments, the organometallic compound represented by Formula 1 may satisfy one of <Condition 1-6>and <Condition 1-7>: [0130] <Condition 1-6>

[0131] Y.sub.2 is not a chemical bond, and L.sub.3 is not a single bond; and [0132] <Condition 1-7>

[0133] Y.sub.3 is not a chemical bond, and L.sub.1 is not a single bond.

[0134] In an embodiment, the organometallic compound may have a triplet metal-to-ligand charge transfer (.sup.3MLCT) value of 20% or more, 21% or more, 22% or more, or 23% or more.

[0135] In an embodiment, the organometallic compound may be one of Compounds D1 to D67:

##STR00015## ##STR00016## ##STR00017## ##STR00018## ##STR00019## ##STR00020## ##STR00021## ##STR00022## ##STR00023## ##STR00024## ##STR00025## ##STR00026## ##STR00027## ##STR00028## ##STR00029## ##STR00030## ##STR00031## ##STR00032## ##STR00033## ##STR00034## ##STR00035## ##STR00036## ##STR00037##

[0136] The organometallic compound represented by Formula 1 has a structure in which M, which is a metal, is bonded to at least one of ring CY.sub.1 to ring CY.sub.4 via a linker that is not a chemical bond (for example, oxygen, etc.), and at least one of L.sub.1 to L.sub.3, which are linkers between ring CY.sub.1 to ring CY.sub.4, is not a single bond. That is, M is bonded to at least one of ring CY.sub.1 to ring CY.sub.4 via a linker that is O, S, or Se (i.e., not a chemical bond) and at least one of L.sub.1 to L.sub.3 is not a single bond.

[0137] Because of such a structure, a planar structure may be easily formed in the organometallic compound, and as a result, a structure in a ground state may be stabilized, thereby obtaining a high .sup.3MLCT value. Accordingly, the usage of the organometallic compound may improve efficiency characteristics of a light-emitting device, and may realize (e.g., provide) an electronic device (for example, an organic light-emitting device) having high efficiency characteristics.

[0138] The highest occupied molecular orbital (HOMO) energy level, the lowest unoccupied molecular orbital (LUMO) energy level, the bandgap, the Ti energy level, the maximum emission wavelength (λmax), and the .sup.3MLCT of some compounds of the organometallic compound represented by Formula 1 and comparative compounds are evaluated utilizing the density functional theory (DFT) method of the Gaussian program (structurally optimized at the level of B3LYP, 6-31G(d,p)), and results thereof are shown in Table 1. In Table 1, Ti is a value obtained by calculating the energy when molecules of a compound are excited from a ground state to a triplet (T.sub.1) state.

TABLE-US-00001 TABLE 1 Com- HOMO LUMO Bandgap T.sub.1 λ max pound (eV) (eV) (eV) (eV) (nm) .sup.3MLCT Example 1 D1 −4.64 −2.03 2.61 2.37 522 65 Example 2 D2 −4.69 −1.98 2.71 2.31 537 56 Example 3 D3 −4.65 −2.03 2.61 2.36 526 55 Example 4 D4 −4.62 −2.05 2.58 2.34 531 55 Example 5 D5 −4.74 −2.06 2.68 2.35 528 53 Example 6 D6 −4.70 −2.05 2.66 2.31 537 48 Example 7 D7 −4.67 −2.05 2.63 2.36 525 47 Example 8 D8 −4.61 −2.04 2.57 2.34 530 47 Example 9 D9 −4.65 −1.69 2.96 2.37 523 46 Example 10 D10 −4.74 −2.01 2.72 2.38 520 42 Example 11 D11 −4.70 −2.09 2.61 2.35 527 41 Example 12 D12 −4.68 −2.08 2.60 2.36 525 41 Example 13 D13 −4.65 −2.05 2.61 2.36 526 40 Example 14 D14 −4.71 −2.00 2.71 2.38 521 39 Example 15 D15 −4.75 −2.03 2.72 2.39 519 37 Example 16 D16 −4.66 −1.98 2.68 2.38 522 35 Example 17 D17 −5.22 −2.22 3.00 2.06 602 33 Example 18 D18 −4.62 −1.28 3.33 2.47 503 31 Example 19 D19 −4.73 −2.11 2.62 2.02 615 30 Example 20 D20 −4.81 −1.44 3.36 2.46 504 30 Example 21 D21 −4.84 −2.09 2.75 2.05 605 29 Example 22 D22 −5.06 −1.78 3.27 2.23 557 29 Example 24 D24 −4.88 −1.14 3.74 2.60 477 29 Example 25 D25 −4.91 −1.15 3.76 2.62 473 29 Example 26 D26 −5.04 −1.98 3.06 2.26 550 27 Example 27 D27 −4.84 −2.15 2.69 1.93 641 27 Example 28 D28 −4.92 −2.10 2.82 2.00 621 27 Example 29 D29 −4.82 −1.10 3.72 2.62 474 27 Example 30 D30 −4.97 −1.97 3.01 1.81 685 26 Example 31 D31 −5.02 −1.79 3.23 2.39 519 26 Example 32 D32 −4.77 −2.11 2.67 2.38 520 26 Example 33 D33 −4.99 −1.86 3.13 2.22 558 26 Example 34 D34 −5.05 −1.45 3.60 2.53 491 26 Example 35 D35 −4.68 −1.44 3.23 2.54 489 25 Example 36 D36 −4.86 −1.30 3.56 2.61 474 25 Example 37 D37 −4.90 −1.04 3.85 2.57 482 25 Example 38 D38 −5.01 −2.01 3.01 1.81 684 25 Example 39 D39 −4.89 −1.97 2.92 2.39 519 25 Example 40 D40 −4.84 −1.54 3.31 2.48 500 25 Example 41 D41 −5.05 −1.22 3.84 2.53 491 25 Example 42 D42 −4.78 −1.42 3.36 2.47 502 25 Example 43 D43 −4.69 −1.06 3.63 2.54 487 25 Example 44 D44 −5.12 −2.00 3.12 1.81 684 24 Example 45 D45 −5.04 −1.92 3.13 2.27 547 24 Example 46 D46 −4.87 −1.01 3.86 2.69 461 24 Example 47 D47 −4.92 −1.54 3.39 2.46 504 24 Example 48 D48 −5.10 −2.25 2.85 2.06 602 23 Example 49 D49 −5.28 −2.08 3.20 1.94 639 23 Example 50 D50 −4.87 −1.85 3.01 2.42 512 23 Example 51 D51 −5.12 −1.94 3.18 2.27 547 23 Example 52 D52 −4.67 −2.05 2.63 2.38 522 66 Example 53 D53 −4.64 −2.03 2.62 2.37 522 65 Example 54 D54 −4.68 −2.08 2.60 2.37 523 63 Example 55 D55 −4.64 −2.03 2.61 2.32 534 55 Example 56 D56 −4.65 −2.04 2.61 2.35 527 55 Example 57 D57 −4.66 −2.03 2.64 2.29 541 52 Example 58 D58 −4.68 −2.04 2.64 2.37 524 46 Example 59 D59 −4.68 −2.04 2.63 2.37 524 45 Example 60 D60 −4.80 −2.06 2.74 2.40 517 45 Example 61 D61 −4.64 −2.03 2.61 2.36 526 43 Example 62 D62 −4.71 −2.00 2.71 2.38 521 40 Example 63 D63 −4.74 −2.09 2.65 2.37 522 33 Example 64 D64 −4.66 −1.97 2.69 2.37 522 33 Example 65 D65 −4.71 −2.01 2.70 2.38 521 32 Example 66 D66 −4.74 −2.09 2.65 2.38 522 26 Comparative R2 −5.01 −1.88 3.13 2.32 525  5.84 Example 2 Comparative R3 −4.87 −1.76 3.11 2.40 497  1.06 Example 3 Comparative R4 −4.86 −2.29 2.57 1.87 662  9.23 Example 4 Comparative R5 −5.62 −2.09 3.53 2.68 463 10.37 Example 5 Comparative R6 −4.78 −1.71 3.07 2.12 585  6.4 Example 6 Comparative R7 −4.80 −1.73 3.07 2.12 585  6.3 Example 7 Comparative R8 −4.78 −1.78 3.00 2.05 605  5.3 Example 8 [00038][00039][00040][00041][00042][00043][00044]

[0139] From Table 1, it is confirmed that the compounds represented by Formula 1 according to the present disclosure show higher .sup.3MLCT value and have excellent or suitable characteristics as a luminescent material.

[0140] Methods of synthesizing the organometallic compound represented by Formula 1 may be easily understood to those of ordinary skill in the art by referring to Synthesis Examples and/or Examples described herein.

[0141] In an embodiment,

[0142] the first electrode of the light-emitting device may be an anode,

[0143] the second electrode of the light-emitting device may be a cathode,

[0144] the interlayer may further include a hole transport region located between the first electrode and the emission layer and an electron transport region located between the emission layer and the second electrode,

[0145] the hole transport region may include a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and

[0146] the electron transport region may include a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.

[0147] In one or more embodiments, the interlayer of the light-emitting device may include the organometallic compound represented by Formula 1.

[0148] In one or more embodiments, the emission layer of the light-emitting device may include the organometallic compound represented by Formula 1.

[0149] In one or more embodiments, the emission layer may be to emit red light, green light, or blue light.

[0150] In one or more embodiments, the emission layer of the light-emitting device may include a dopant and a host, and the organometallic compound represented by Formula 1 may be included in the dopant. For example, the organometallic compound may act (e.g., serve) as a dopant. For example, the emission layer may be to emit red light, green light, or blue light.

[0151] In one or more embodiments, the electron transport region of the light-emitting device may include a hole blocking layer, and the hole blocking layer may include a phosphine oxide-containing compound, a silicon-containing compound, or any combination thereof. For example, the hole blocking layer may be in direct contact with the emission layer.

[0152] In one or more embodiments, the light-emitting device may further include at least one of a first capping layer located outside the first electrode or a second capping layer located outside the second electrode, and the organometallic compound represented by Formula 1 may be included in at least one of the first capping layer or the second capping layer. The first capping layer and/or the second capping layer are respectively the same those as described herein.

[0153] In an embodiment, the light-emitting device may include:

[0154] a first capping layer located outside the first electrode and including the organometallic compound represented by Formula 1;

[0155] a second capping layer located outside the second electrode and including the organometallic compound represented by Formula 1; or

[0156] the first capping layer and the second capping layer.

[0157] The expression “(interlayer and/or capping layer) includes an organometallic compound” as used herein may be understood as “(interlayer and/or capping layer) may include one kind of organometallic compound represented by Formula 1 or two different kinds of organometallic compounds, each represented by Formula 1.”

[0158] For example, the interlayer and/or the capping layer may include only Compound 1 as the organometallic compound. In this regard, a Compound 1 may be present in the emission layer of the light-emitting device. In one or more embodiments, the interlayer may include, as the organometallic compound, Compound 1 and Compound 2. In this regard, Compound 1 and Compound 2 may be present in substantially the same layer (for example, both (e.g., simultaneously) Compound 1 and Compound 2 may be present in the emission layer), or may be present in different layers (for example, Compound 1 may be present in the emission layer, and Compound 2 may be present in the electron transport region).

[0159] The term “interlayer” as used herein refers to a single layer and/or all of a plurality of layers located between the first electrode and the second electrode of the light-emitting device.

Description of FIG. 1

[0160] FIG. 1 is a schematic cross-sectional view of a light-emitting device 10 according to an embodiment. The light-emitting device 10 includes a first electrode 110, an interlayer 130, and a second electrode 150.

[0161] Hereinafter, the structure of the light-emitting device 10 according to an embodiment and a method of manufacturing the light-emitting device 10 will be described with reference to FIG. 1.

First electrode 110

[0162] In FIG. 1, a substrate may be additionally disposed under the first electrode 110 and/or on the second electrode 150. As the substrate, a glass substrate or a plastic substrate may be utilized. In one or more embodiments, the substrate may be a flexible substrate, and may include plastics with excellent or suitable heat resistance and durability, such as polyimide, polyethylene terephthalate (PET), polycarbonate, polyethylene naphthalate, polyarylate (PAR), polyetherimide, or any combination thereof.

[0163] The first electrode 110 may be formed by, for example, depositing or sputtering a material for forming the first electrode 110 on the substrate. When the first electrode 110 is an anode, the material for forming the first electrode 110 may be a high work function material that facilitates injection of holes.

[0164] The first electrode 110 may be a reflective electrode, a semi-transmissive electrode, or a transmissive electrode. When the first electrode 110 is a transmissive electrode, the material for forming the first electrode 110 may include indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO.sub.2), zinc oxide (ZnO), or any combination thereof. In one or more embodiments, when the first electrode 110 is a semi-transmissive electrode or a reflective electrode, the material for forming the first electrode 110 may include magnesium (Mg), silver (Ag), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), magnesium-silver (Mg—Ag), or any combination thereof.

[0165] The first electrode 110 may have a single-layered structure consisting of a single layer or a multi-layered structure including a plurality of layers. For example, the first electrode 110 may have a three-layered structure of ITO/Ag/ITO.

Interlayer 130

[0166] The interlayer 130 is disposed on the first electrode 110. The interlayer 130 includes an emission layer.

[0167] The interlayer 130 may further include a hole transport region located between the first electrode 110 and the emission layer and an electron transport region located between the emission layer and the second electrode 150.

[0168] The interlayer 130 may further include, in addition to one or more suitable organic materials, a metal-containing compound, such as an organometallic compound, an inorganic material, such as a quantum dot, and/or the like.

[0169] In one or more embodiments, the interlayer 130 may include, i) two or more emitting units sequentially stacked between the first electrode 110 and the second electrode 150, and ii) a charge generation layer located between the two or more emitting units. When the interlayer 130 includes the two or more emitting units and the charge generation layer as described above, the light-emitting device 10 may be a tandem light-emitting device.

Hole Transport Region in Interlayer 130

[0170] The hole transport region may have i) a single-layered structure consisting of a single layer consisting of a single material, ii) a single-layered structure consisting of a single layer including (e.g., consisting of) a plurality of different materials, or iii) a multi-layered structure including a plurality of layers including different materials.

[0171] The hole transport region may include a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof.

[0172] For example, the hole transport region may have a multi-layered structure including a hole injection layer/hole transport layer structure, a hole injection layer/hole transport layer/emission auxiliary layer structure, a hole injection layer/emission auxiliary layer structure, a hole transport layer/emission auxiliary layer structure, or a hole injection layer/hole transport layer/electron blocking layer structure, with the constituting layers of each structure being stacked sequentially from the first electrode 110 in the respective stated order.

[0173] The hole transport region may include a compound represented by Formula 201, a compound represented by Formula 202, or any combination thereof:

##STR00045##

[0174] wherein, in Formulae 201 and 202,

[0175] L.sub.201 to L.sub.204 may each independently be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a,

[0176] L.sub.205 may be *—O—*′, *—N(Q.sub.201)—*′, a C.sub.1-C.sub.20 alkylene group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.20 alkenylene group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a,

[0177] xa1 to xa4 may each independently be an integer from 0 to 5,

[0178] xa5 may be an integer from 1 to 10,

[0179] R.sub.201 to R.sub.204 and Q.sub.201 may each independently be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a,

[0180] R.sub.201 and R.sub.202 may optionally be linked to each other via a single bond, a C.sub.1-C.sub.5 alkylene group unsubstituted or substituted with at least one R.sub.10a, or a C.sub.2-C.sub.5 alkenylene group unsubstituted or substituted with at least one R.sub.10a to form a C.sub.8-C.sub.60 polycyclic group (for example, a carbazole group, etc.) unsubstituted or substituted with at least one R.sub.10a (for example, see Compound HT16, etc.),

[0181] R.sub.203 and R.sub.204 may optionally be linked to each other via a single bond, a C.sub.1-C.sub.5 alkylene group unsubstituted or substituted with at least one R.sub.10a, or a C.sub.2-C.sub.5 alkenylene group unsubstituted or substituted with at least one R.sub.10a to form a C.sub.8-C.sub.60 polycyclic group unsubstituted or substituted with at least one R.sub.10a, and

[0182] na1 may be an integer from 1 to 4.

[0183] In one or more embodiments, each of Formulae 201 and 202 may include at least one of the groups represented by Formulae CY201 to CY217:

##STR00046## ##STR00047## ##STR00048## ##STR00049## ##STR00050## ##STR00051## ##STR00052##

[0184] wherein, in Formulae CY201 to CY217, R.sub.10b and R.sub.10c are each the same as described in connection with R.sub.10a, ring CY201 to ring CY204 may each independently be a C.sub.3-C.sub.20 carbocyclic group or a C.sub.1-C.sub.20 heterocyclic group, and at least one hydrogen in Formulae CY201 to CY217 may be unsubstituted or substituted with R.sub.10a as described herein.

[0185] In an embodiment, ring CY201 to ring CY204 in Formulae CY201 to CY217 may each independently be a benzene group, a naphthalene group, a phenanthrene group, or an anthracene group.

[0186] In one or more embodiments, each of Formulae 201 and 202 may include at least one of the groups represented by Formulae CY201 to CY203.

[0187] In one or more embodiments, Formula 201 may include at least one of the groups represented by Formulae CY201 to CY203 and at least one of the groups represented by Formulae CY204 to CY217.

[0188] In one or more embodiments, in Formula 201, xa1 may be 1, R.sub.201 may be a group represented by one of Formulae CY201 to CY203, xa2 may be 0, and R.sub.202 may be a group represented by one of Formulae CY204 to CY207.

[0189] In one or more embodiments, each of Formulae 201 and 202 may not include (e.g., may exclude) any of the groups represented by Formulae CY201 to CY203.

[0190] In one or more embodiments, each of Formulae 201 and 202 may not include (e.g., may exclude) any of the groups represented by Formulae CY201 to CY203, and may include at least one of the groups represented by Formulae CY204 to CY217.

[0191] In one or more embodiments, each of Formulae 201 and 202 may not include (e.g., may exclude) any of the groups represented by Formulae CY201 to CY217.

[0192] In an embodiment, the hole transport region may include at least one of Compounds HT1 to HT46, m-MTDATA, TDATA, 2-TNATA, NPB(NPD), β-NPB, TPD, Spiro-TPD, Spiro-NPB, methylated NPB, TAPC, HMTPD, 4,4′,4″-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline/dodecylbenzenesulfonic acid (PANI/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphor sulfonic acid (PANI/CSA), polyaniline/poly(4-styrenesulfonate) (PANI/PSS), or any combination thereof:

##STR00053## ##STR00054## ##STR00055## ##STR00056## ##STR00057## ##STR00058## ##STR00059## ##STR00060## ##STR00061## ##STR00062## ##STR00063## ##STR00064##

[0193] A thickness of the hole transport region may be in a range of about 50 Å to about 10,000 Å, for example, about 100 Å to about 4,000 Å. When the hole transport region includes a hole injection layer, a hole transport layer, or any combination thereof, a thickness of the hole injection layer may be in a range of about 100 Å to about 9,000 Å, for example, about 100 Å to about 1,000 Å, and a thickness of the hole transport layer may be in a range of about 50 Å to about 2,000 Å, for example, about 100 Å to about 1,500 Å. When the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within these ranges, satisfactory hole transporting characteristics may be obtained without a substantial increase in driving voltage.

[0194] The emission auxiliary layer may increase light-emission efficiency by compensating for an optical resonance distance according to the wavelength of light emitted by the emission layer, and the electron blocking layer may block or reduce the leakage of electrons from the emission layer to the hole transport region. Materials that may be included in the hole transport region may be included in the emission auxiliary layer and the electron blocking layer.

p-dopant

[0195] The hole transport region may further include, in addition to these materials, a charge-generation material for the improvement of conductive properties. The charge-generation material may be uniformly or non-uniformly dispersed in the hole transport region (for example, in the form of a single layer consisting of a charge-generation material).

[0196] The charge-generation material may be, for example, a p-dopant.

[0197] In one or more embodiments, the LUMO energy level of the p-dopant may be −3.5 eV or less.

[0198] In an embodiment, the p-dopant may include a quinone derivative, a cyano group-containing compound, a compound containing element EL1 and element EL.sub.2 (to be described in more detail below), or any combination thereof.

[0199] Examples of the quinone derivative may include TCNQ, F4-TCNQ, and/or the like.

[0200] Examples of the cyano group-containing compound may include HAT-CN and a compound represented by Formula 221:

##STR00065##

[0201] wherein, in Formula 221,

[0202] R.sub.221 to R.sub.223 may each independently be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, and

[0203] at least one of R.sub.221 to R.sub.223 may each independently be a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each substituted with a cyano group; —F; —Cl; —Br; —I; a C.sub.1-C.sub.20 alkyl group substituted with a cyano group, —F, —Cl, —Br, —I, or any combination thereof; or any combination thereof.

[0204] In the compound containing element EL1 and element EL.sub.2, element EL1 may be a metal, a metalloid, or any combination thereof, and element EL.sub.2 may be a non-metal, a metalloid, or any combination thereof.

[0205] Examples of the metal may include: an alkali metal (for example, lithium (Li), sodium (Na), potassium (K), rubidium (Rb), cesium (Cs), etc.); an alkaline earth metal (for example, beryllium (Be), magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba), etc.); a transition metal (for example, titanium (T.sub.1), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), manganese (Mn), technetium (Tc), rhenium (Re), iron (Fe), ruthenium (Ru), osmium (Os), cobalt (Co), rhodium (Rh), iridium (Ir), nickel (Ni), palladium (Pd), platinum (Pt), copper (Cu), silver (Ag), gold (Au), etc.); a post-transition metal (for example, zinc (Zn), indium (In), tin (Sn), etc.); and a lanthanide metal (for example, lanthanum (La), cerium (Ce), praseodymium (Pr), neodymium (Nd), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), lutetium (Lu), etc.).

[0206] Examples of the metalloid may include silicon (Si), antimony (Sb), and tellurium (Te).

[0207] Examples of the non-metal may include oxygen (O) and halogen (for example, F, Cl, Br, I, etc.).

[0208] For example, the compound containing element EL1 and element EL.sub.2 may include a metal oxide, a metal halide (for example, a metal fluoride, a metal chloride, a metal bromide, a metal iodide, etc.), a metalloid halide (for example, a metalloid fluoride, a metalloid chloride, a metalloid bromide, a metalloid iodide, etc.), a metal telluride, or any combination thereof.

[0209] Examples of the metal oxide may include tungsten oxide (for example, WO, W.sub.2O.sub.3, WO.sub.2, WO.sub.3, W.sub.2O.sub.5, etc.), vanadium oxide (for example, VO, V.sub.2O.sub.3, V).sub.2, V.sub.2O.sub.5, etc.), molybdenum oxide (MoO, Mo.sub.2O.sub.3, MoO.sub.2, MoO.sub.3, Mo.sub.2O.sub.5, etc.), and rhenium oxide (for example, ReO.sub.3, etc.).

[0210] Examples of the metal halide may include an alkali metal halide, an alkaline earth metal halide, a transition metal halide, a post-transition metal halide, and a lanthanide metal halide.

[0211] Examples of the alkali metal halide may include LiF, NaF, KF, RbF, CsF, LiCl, NaCl, KCl, RbCl, CsCl, LiBr, NaBr, KBr, RbBr, CsBr, Lil, Nal, KI, RbI, and CsI.

[0212] Examples of the alkaline earth metal halide may include BeF.sub.2, MgF.sub.2, CaF.sub.2, SrF.sub.2, BaF.sub.2, Becl.sub.2, Mgcl.sub.2, Cacl.sub.2, SrCl.sub.2, Bacl.sub.2, BeBr.sub.2, MgBr.sub.2, CaBr.sub.2, SrBr.sub.2, BaBr.sub.2, BeI.sub.2, MgI.sub.2, CaI.sub.2, SrI.sub.2, and BaI.sub.2.

[0213] Examples of the transition metal halide may include titanium halide (for example, TiF.sub.4, TiCl.sub.4, TiBr.sub.4, TiI.sub.4, etc.), zirconium halide (for example, ZrF.sub.4, ZrCl.sub.4, ZrBr.sub.4, ZrI.sub.4, etc.), hafnium halide (for example, HfF.sub.4, HfC.sub.14, HfBr.sub.4, HfI.sub.4, etc.), vanadium halide (for example, VF.sub.3, VCl.sub.3, VBr.sub.3, VI.sub.3, etc.), niobium halide (for example, NbF.sub.3, NbC.sub.13, NbBr.sub.3, NbI.sub.3, etc.), tantalum halide (for example, TaF.sub.3, TaCl.sub.3, TaBr.sub.3, Tal.sub.3, etc.), chromium halide (for example, CrF.sub.3, CrCl.sub.3, CrBr.sub.3, CrI.sub.3, etc.), molybdenum halide (for example, MoF.sub.3, MoCl.sub.3, MoBr.sub.3, Mol.sub.3, etc.), tungsten halide (for example, WF.sub.3, WCl.sub.3, WBr.sub.3, WI.sub.3, etc.), manganese halide (for example, MnF.sub.2, Mncl.sub.2, MnBr.sub.2, MnI.sub.2, etc.), technetium halide (for example, TcF.sub.2, Tccl.sub.2, TcBr.sub.2, TcI.sub.2, etc.), rhenium halide (for example, ReF.sub.2, Recl.sub.2, ReBr.sub.2, ReI.sub.2, etc.), iron halide (for example, FeF.sub.2, Fecl.sub.2, FeBr.sub.2, FeI.sub.2, etc.), ruthenium halide (for example, RuF.sub.2, Rucl.sub.2, RuBr.sub.2, RuI.sub.2, etc.), osmium halide (for example, OsF.sub.2, Oscl.sub.2, OsBr2, 0s12, etc.), cobalt halide (for example, CoF.sub.2, CoCl.sub.2, CoBr.sub.2, CoI.sub.2, etc.), rhodium halide (for example, RhF.sub.2, RhCl.sub.2, RhBr.sub.2, RhI.sub.2, etc.), iridium halide (for example, IrF.sub.2, IrCl.sub.2, IrBr.sub.2, IrI.sub.2, etc.), nickel halide (for example, NiF.sub.2, NiCl.sub.2, NiBr.sub.2, NiI.sub.2, etc.), palladium halide (for example, PdF.sub.2, Pdcl.sub.2, PdBr.sub.2, PdI.sub.2, etc.), platinum halide (for example, PtF.sub.2, Ptcl.sub.2, PtBr.sub.2, PtI.sub.2, etc.), copper halide (for example, CuF, CuCl, CuBr, Cul, etc.), silver halide (for example, AgF, AgCl, AgBr, AgI, etc.), and gold halide (for example, AuF, AuCl, AuBr, Aul, etc.).

[0214] Examples of the post-transition metal halide may include zinc halide (for example, ZnF.sub.2, ZnCl.sub.2, ZnBr.sub.2, ZnI.sub.2, etc.), indium halide (for example, InI.sub.3, etc.), and tin halide (for example, SnI.sub.2, etc.).

[0215] Examples of the lanthanide metal halide may include YbF, YbF.sub.2, YbF.sub.3, SmF.sub.3, YbCl, YbCl.sub.2, YbCl.sub.3, SmCl.sub.3, YbBr, YbBr.sub.2, YbBr.sub.3, SmBr.sub.3, YbI, YbI.sub.2, YbI.sub.3, and SmI.sub.3.

[0216] Examples of the metalloid halide may include antimony halide (for example, SbCl.sub.5, etc.).

[0217] Examples of the metal telluride may include an alkali metal telluride (for example, Li.sub.2Te, Na.sub.2Te, K.sub.2Te, Rb.sub.2Te, Cs.sub.2Te, etc.), an alkaline earth metal telluride (for example, BeTe, MgTe, CaTe, SrTe, BaTe, etc.), a transition metal telluride (for example, TiTe.sub.2, ZrTe.sub.2, HfTe.sub.2, V.sub.2Te.sub.3, Nb.sub.2Te.sub.3, Ta.sub.2Te.sub.3, Cr.sub.2Te.sub.3, Mo.sub.2Te.sub.3, W.sub.2Te.sub.3, MnTe, TcTe, ReTe, FeTe, RuTe, OsTe, CoTe, RhTe, IrTe, NiTe, PdTe, PtTe, Cu.sub.2Te, CuTe, Ag.sub.2Te, AgTe, Au.sub.2Te, etc.), a post-transition metal telluride (for example, ZnTe, etc.), and a lanthanide metal telluride (for example, LaTe, CeTe, PrTe, NdTe, PmTe, EuTe, GdTe, TbTe, DyTe, HoTe, ErTe, TmTe, YbTe, LuTe, etc.).

Emission Layer in Interlayer 130

[0218] When the light-emitting device 10 is a full-color light-emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, and/or a blue emission layer, according to a subpixel. In one or more embodiments, the emission layer may have a stacked structure of two or more layers seleted from a red emission layer, a green emission layer, and a blue emission layer, in which the two or more layers contact each other or are separated from each other to emit white light. In one or more embodiments, the emission layer may have a structure in which two or more materials selected from a red light-emitting material, a green light-emitting material, and a blue light-emitting material are mixed with each other in a single layer to emit white light.

[0219] The emission layer may include a host and a dopant. The dopant may include a phosphorescent dopant, a fluorescent dopant, or any combination thereof.

[0220] An amount of the dopant in the emission layer may be in a range of about 0.01 part by weight to about 15 parts by weight based on 100 parts by weight of the host.

[0221] In one or more embodiments, the emission layer may include a quantum dot.

[0222] In one or more embodiments, the emission layer may include a delayed fluorescence material. The delayed fluorescence material may act (e.g., serve) as a host or a dopant in the emission layer.

[0223] A thickness of the emission layer may be in a range of about 100 Å to about 1,000 Å, for example, about 200 Å to about 600 Å. When the thickness of the emission layer is within these ranges, excellent or suitable light-emission characteristics may be obtained without a substantial increase in driving voltage.

Host

[0224] The host may include a compound represented by Formula 301:

[Ar.sub.301].sub.xb11−[(L.sub.301).sub.xb1−R.sub.301].sub.xb21   Formula 301

[0225] wherein, in Formula 301,

[0226] Ar.sub.301 and L.sub.301 may each independently be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a,

[0227] xb11 may be 1, 2, or 3,

[0228] xb1 may be an integer from 0 to 5,

[0229] R.sub.301 may be hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, —Si(Q.sub.301)(Q.sub.302)(Q.sub.303), —N(Q.sub.301)(Q.sub.302), —B(Q.sub.301)(Q.sub.302), —C(═O)(Q.sub.301), —S(═O).sub.2(Q.sub.301), or —P(═O)(Q.sub.301)(Q.sub.302),

[0230] xb21 may be an integer from 1 to 5, and

[0231] Q.sub.301 to Q.sub.303 may each independently be the same as described in connection with Q.sub.1.

[0232] For example, when xb11 in Formula 301 is 2 or more, two or more of Ar.sub.301(s) may be linked to each other via a single bond.

[0233] In one or more embodiments, the host may include a compound represented by Formula 301-1, a compound represented by Formula 301-2, or any combination thereof:

##STR00066##

[0234] wherein, in Formulae 301-1 and 301-2,

[0235] ring A.sub.301 to ring A.sub.304 may each independently be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a,

[0236] X.sub.301 may be O, S, N-[(L.sub.304).sub.xb4-R.sub.304], C(R.sub.304)(R.sub.305), or Si(R.sub.304)(R.sub.305),

[0237] xb22 and xb23 may each independently be 0, 1, or 2,

[0238] L.sub.301, xb1, and R.sub.301 may each independently be the same as respectively described herein,

[0239] L.sub.302 to L.sub.304 may each independently be the same as described in connection with L.sub.301,

[0240] xb2 to xb4 may each independently be the same as described in connection with xb1, and

[0241] R.sub.302 to R.sub.305 and R.sub.311 to R.sub.314 may each independently be the same as described in connection with R.sub.301.

[0242] In one or more embodiments, the host may include an alkaline earth metal complex, a post-transition metal complex, or any combination thereof. For example, the host may include a Be complex (for example, Compound H55), an Mg complex, a Zn complex, or any combination thereof.

[0243] In one or more embodiments, the host may include at least one of Compounds H1 to H128, 9,10-di(2-naphthyl)anthracene (ADN), 2-methyl-9,10-bis(naphthalen-2-yl)anthracene (MADN), 9,10-di-(2-naphthyl)-2-t-butyl-anthracene (TBADN), 4,4′-bis(N-carbazolyl)-1,1′-biphenyl (CBP), 1,3-di-9-carbazolylbenzene (mCP), 1,3,5-tri(carbazol-9-yl)benzene (TCP), or any combination thereof:

##STR00067## ##STR00068## ##STR00069## ##STR00070## ##STR00071## ##STR00072## ##STR00073## ##STR00074## ##STR00075## ##STR00076## ##STR00077## ##STR00078## ##STR00079## ##STR00080## ##STR00081## ##STR00082## ##STR00083## ##STR00084## ##STR00085## ##STR00086## ##STR00087## ##STR00088## ##STR00089## ##STR00090## ##STR00091## ##STR00092## ##STR00093## ##STR00094## ##STR00095## ##STR00096## ##STR00097##

Phosphorescent Dopant

[0244] The phosphorescent dopant may include at least one transition metal as a central metal.

[0245] The phosphorescent dopant may include a monodentate ligand, a bidentate ligand, a tridentate ligand, a tetradentate ligand, a pentadentate ligand, a hexadentate ligand, or any combination thereof.

[0246] The phosphorescent dopant may be electrically neutral.

[0247] In an embodiment, the phosphorescent dopant may include an organometallic compound represented by Formula 401:

M(L.sub.401).sub.xc1(L.sub.402).sub.xc2   Formula 401

##STR00098##

[0248] wherein, in Formulae 401 and 402,

[0249] M may be a transition metal (for example, iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (T.sub.1), gold (Au), hafnium (Hf), europium (Eu), terbium (Tb), rhodium (Rh), rhenium (Re), or thulium (Tm)),

[0250] L.sub.401 may be a ligand represented by Formula 402, and xc1 may be 1, 2, or 3, wherein, when xc1 is 2 or more, two or more of L.sub.401(s) may be identical to or different from each other,

[0251] L.sub.402 may be an organic ligand, and xc2 may be 0, 1, 2, 3, or 4, wherein, when xc2 is 2 or more, two or more of L.sub.402(s) may be identical to or different from each other,

[0252] X.sub.401 and X.sub.402 may each independently be nitrogen or carbon,

[0253] ring A.sub.401 and ring A.sub.402 may each independently be a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group,

[0254] T.sub.401 may be a single bond, *—O—*′, *—S—*′, *—C(═O)—*′, *—N(Q.sub.411)—*′, *—C(Q.sub.411)(Q.sub.412)—*′, *—C(Q.sub.411)═C(Q.sub.412)—*′, *—C(Q.sub.411)=*′, or *′C=*′,

[0255] X.sub.403 and X.sub.404 may each independently be a chemical bond (for example, a covalent bond or a coordination bond), O, S, N(Q.sub.413), B(Q.sub.413), P(Q.sub.413), C(Q.sub.413)(Q.sub.414), or Si(Q.sub.413)(Q.sub.414),

[0256] Q.sub.411 to Q.sub.414 may each independently be the same as described in connection with Q.sub.1,

[0257] R.sub.401 and R.sub.402 may each independently be hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.20 alkoxy group unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, —Si(Q.sub.401)(Q.sub.402)(Q.sub.403), —N(Q.sub.401)(Q.sub.402), —B(Q.sub.401)(Q.sub.402), —C(.sup.═O)(Q.sub.401), —S(═O).sub.2(Q.sub.401), or —P(═O)(Q.sub.401)(Q.sub.402),

[0258] Q.sub.401 to Q.sub.403 may each independently be the same as described in connection with Q.sub.1,

[0259] xc11 and xc12 may each independently be an integer from 0 to 10, and

[0260] * and *′ in Formula 402 each indicate a binding site to M in Formula 401.

[0261] In an embodiment, in Formula 402, i) X.sub.401 may be nitrogen, and X.sub.402 may be carbon, or ii) each of X.sub.401 and X.sub.402 may be nitrogen.

[0262] In one or more embodiments, when xc1 in Formula 401 is 2 or more, two ring A.sub.401(s) in two or more of L.sub.401(s) may optionally be linked to each other via T.sub.402, which is a linking group, and/or two ring A.sub.402(s) may be optionally be linked to each other via T4o3, which is a linking group (see Compounds PD1 to PD4 and PD7). T.sub.402 and T4o3 are each independently the same as described in connection with T.sub.401.

[0263] L.sub.402 in Formula 401 may be an organic ligand. For example, L.sub.402 may include a halogen group, a diketone group (for example, an acetylacetonate group), a carboxylic acid group (for example, a picolinate group), —C(═O), an isonitrile group, a —CN group, a phosphorus group (for example, a phosphine group, a phosphite group, etc.), or any combination thereof.

[0264] The phosphorescent dopant may include, for example, at least one of compounds PD1 to PD39, or any combination thereof:

##STR00099## ##STR00100## ##STR00101## ##STR00102## ##STR00103## ##STR00104## ##STR00105## ##STR00106## ##STR00107## ##STR00108##

Fluorescent Dopant

[0265] The fluorescent dopant may include an amine group-containing compound, a styryl group-containing compound, or any combination thereof.

[0266] In one or more embodiments, the fluorescent dopant may include a compound represented by Formula 501:

##STR00109##

[0267] wherein, in Formula 501,

[0268] Ar.sub.501, L.sub.501 to L.sub.503, R.sub.501, and R.sub.502 may each independently be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a,

[0269] xd1 to xd3 may each independently be 0, 1, 2, or 3, and

[0270] xd4 may be 1, 2, 3, 4, 5, or 6.

[0271] In one or more embodiments, Ar.sub.501 in Formula 501 may be a condensed cyclic group (for example, an anthracene group, a chrysene group, a pyrene group, etc.) in which three or more monocyclic groups are condensed together.

[0272] In one or more embodiments, xd4 in Formula 501 may be 2.

[0273] For example, the fluorescent dopant may include: at least one of Compounds FD1 to FD36; DPVBi; DPAVBi; or any combination thereof:

##STR00110## ##STR00111## ##STR00112## ##STR00113## ##STR00114## ##STR00115## ##STR00116##

Delayed Fluorescence Material

[0274] The emission layer may include a delayed fluorescence material.

[0275] In the present specification, the delayed fluorescence material may be selected from compounds capable of emitting delayed fluorescent light based on a delayed fluorescence emission mechanism.

[0276] The delayed fluorescence material included in the emission layer may act (e.g., serve) as a host or a dopant depending on the type or kind of other materials included in the emission layer.

[0277] In an embodiment, a difference between a triplet energy level (eV) of the delayed fluorescence material and a singlet energy level (eV) of the delayed fluorescence material may be equal to or greater than 0 eV and equal to or less than 0.5 eV. When the difference between the triplet energy level (eV) of the delayed fluorescence material and the singlet energy level (eV) of the delayed fluorescence material satisfies the above-described range, up-conversion from the triplet state to the singlet state of the delayed fluorescence materials may effectively occur, and thus, the luminescence efficiency of the light-emitting device 10 may be improved.

[0278] In some embodiments, the delayed fluorescence material may include i) a material including at least one electron donor (for example, a π electron-rich C.sub.3-C.sub.60 cyclic group, such as a carbazole group) and at least one electron acceptor (for example, a sulfoxide group, a cyano group, and/or a π electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group), and/or ii) a material including a C.sub.8-C.sub.60 polycyclic group in which two or more cyclic groups are condensed while sharing boron (B).

[0279] Examples of the delayed fluorescence material may include at least one of Compounds DF1 to DF9:

##STR00117##

Quantum Dot

[0280] The emission layer may include a quantum dot.

[0281] The term “quantum dot” as used herein refers to a crystal of a semiconductor compound, and may include any suitable material capable of emitting light of one or more suitable emission wavelengths according to the size of the crystal.

[0282] A diameter of the quantum dot may be, for example, in a range of about 1 nm to about 10 nm.

[0283] The quantum dot may be synthesized by a wet chemical process, a metal organic chemical vapor deposition process, a molecular beam epitaxy process, or any process similar thereto.

[0284] The wet chemical process is a method including mixing a precursor material with an organic solvent and then growing a quantum dot crystal particle. When the crystal grows, the organic solvent naturally acts (e.g., serves) as a dispersant coordinated on the surface of the quantum dot crystal and controls the growth of the crystal so that the growth of quantum dot particles can be controlled through a lower cost process, which is easier to perform than vapor deposition methods, such as metal organic chemical vapor deposition (MOCVD) and/or molecular beam epitaxy (MBE),

[0285] The quantum dot may include: a Group II-VI semiconductor compound; a Group III-V semiconductor compound; a Group III-VI semiconductor compound; a Group semiconductor compound; a Group IV-VI semiconductor compound; a Group IV element or compound; or any combination thereof.

[0286] Examples of the Group II-VI semiconductor compound may include: a binary compound, such as CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, ZnO, HgS, HgSe, HgTe, MgSe, and/or MgS; a ternary compound, such as CdSeS, CdSeTe, CdSTe, ZnSeS, ZnSeTe, ZnSTe, HgSeS, HgSeTe, HgSTe, CdZnS, CdZnSe, CdZnTe, CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe, HgZnTe, MgZnSe, and/or MgZnS; a quaternary compound, such as CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, HgZnSeTe, and/or HgZnSTe; or any combination thereof.

[0287] Examples of the Group III-V semiconductor compound may include: a binary compound, such as GaN, GaP, GaAs, GaSb, AlN, AlP, AlAs, AlSb, InN, InP, InAs, and/or InSb; a ternary compound, such as GaNP, GaNAs, GaNSb, GaPAs, GaPSb, AlNP, AlNAs, AlNSb, AlPAs, AlPSb, InGaP, InNP, InAlP, InNAs, InNSb, InPAs, and/or InPSb; a quaternary compound, such as GaAlNP, GaAlNAs, GaAlNSb, GaAlPAs, GaAlPSb, GaInNP, GaInNAs, GaInNSb, GaInPAs, GaInPSb, InAlNP, InAlNAs, InAlNSb, InAlPAs, and/or InAlPSb; or any combination thereof. In an embodiment, the Group III-V semiconductor compound may further include a Group II element. Examples of the Group III-V semiconductor compound further including the Group II element may include InZnP, InGaZnP, and InAlZnP.

[0288] Examples of the Group III-VI semiconductor compound may include: a binary compound, such as GaS, GaSe, Ga.sub.2Se3, GaTe, InS, InSe, In.sub.2S.sub.3, In.sub.2Se.sub.3, and/or InTe; a ternary compound, such as InGaS3 and/or InGaSe3; or any combination thereof.

[0289] Examples of the Group semiconductor compound may include: a ternary compound, such as AgInS, AgInS.sub.2, CuInS, CuInS.sub.2, CuGaO.sub.2, AgGaO.sub.2, and/or AgAlO.sub.2; or any combination thereof.

[0290] Examples of the Group IV-VI semiconductor compound may include: a binary compound, such as SnS, SnSe, SnTe, PbS, PbSe, and/or PbTe; a ternary compound, such as SnSeS, SnSeTe, SnSTe, PbSeS, PbSeTe, PbSTe, SnPbS, SnPbSe, and/or SnPbTe; a quaternary compound, such as SnPbSSe, SnPbSeTe, and/or SnPbSTe; or any combination thereof.

[0291] The Group IV element or compound may include: a single element compound, such as Si and/or Ge; a binary compound, such as SiC and/or SiGe; or any combination thereof.

[0292] Each element included in a multi-element compound, such as the binary compound, the ternary compound, and/or the quaternary compound, may be present at a substantially uniform concentration or non-uniform concentration in a particle.

[0293] In an embodiment, the quantum dot may have a single structure in which the concentration of each element in the quantum dot is substantially uniform, or a core-shell dual structure. For example, in a quantum dot with a core-shell structure, a material included in the core and a material included in the shell may be different from each other.

[0294] The shell of the quantum dot may act (e.g., serve) as a protective layer that prevents or reduces chemical degeneration of the core to maintain semiconductor characteristics, and/or as a charging layer that imparts electrophoretic characteristics to the quantum dot. The shell may be a single layer or a multi-layer. The interface between the core and the shell may have a concentration gradient in which the concentration of an element existing in the shell decreases toward the center of the core.

[0295] Examples of the shell of the quantum dot may include an oxide of metal, metalloid, and/or non-metal, a semiconductor compound, or a combination thereof. Examples of the oxide of metal, metalloid, and/or non-metal may include: a binary compound, such as SiO.sub.2, Al.sub.2O.sub.3, TiO.sub.2, ZnO, MnO, Mn.sub.2O.sub.3, Mn.sub.3O.sub.4, CuO, FeO, Fe.sub.2O.sub.3, Fe.sub.3O.sub.4, CoO, Co.sub.3O.sub.4, and/or NiO; a ternary compound, such as MgAl.sub.2O.sub.4, CoFe.sub.2O.sub.4, NiFe.sub.2O.sub.4, and/or CoMn.sub.2O.sub.4; or any combination thereof. Examples of the semiconductor compound may include, as described herein, a Group II-VI semiconductor compound; a Group III-V semiconductor compound; a Group III-VI semiconductor compound; a Group I-III-VI semiconductor compound; a Group IV-VI semiconductor compound; or any combination thereof. For example, the semiconductor compound may include CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, ZnSeS, ZnTeS, GaAs, GaP, GaSb, HgS, HgSe, HgTe, InAs, InP, InGaP, InSb, AlAs, AlP, AlSb, or any combination thereof.

[0296] A full width at half maximum (FWHM) of an emission wavelength spectrum of the quantum dot may be about 45 nm or less, for example, about 40 nm or less, for example, about 30 nm or less, and within these ranges, color purity or color reproducibility may be improved. In addition, because light through the quantum dot is emitted in all directions, a wide viewing angle may be improved.

[0297] In some embodiments, the quantum dot may be in the form of a spherical particle, a pyramidal particle, a multi-arm particle, a cubic nanoparticle, a nanotube particle, a nanowire particle, a nanofiber particle, or a nanoplate particle.

[0298] Because the energy band gap may be adjusted by controlling the size of the quantum dot, light having one or more suitable wavelength bands may be obtained from the emission layer including the quantum dot. Accordingly, by utilizing quantum dots of different sizes, a light-emitting device that emits light of one or more suitable wavelengths may be implemented. For example, the size of the quantum dot may be selected to emit red, green and/or blue light. In some embodiments, the size of the quantum dot may be configured to emit white light by combination of light of one or more suitable colors.

Electron Transport Region in Interlayer 130

[0299] The electron transport region may have i) a single-layered structure consisting of a single layer consisting of a single material, ii) a single-layered structure consisting of a single layer including (e.g., consisting of) a plurality of different materials, or iii) a multi-layered structure including a plurality of layers including different materials.

[0300] The electron transport region may include a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof.

[0301] In an embodiment, the electron transport region may have an electron transport layer/electron injection layer structure, a hole blocking layer/electron transport layer/electron injection layer structure, an electron control layer/electron transport layer/electron injection layer structure, or a buffer layer/electron transport layer/electron injection layer structure, with the constituting layers of each structure being stacked sequentially from the emission layer in the respective stated order.

[0302] The electron transport region (for example, the buffer layer, the hole blocking layer, the electron control layer, and/or the electron transport layer in the electron transport region) may include a metal-free compound including at least one π electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group.

[0303] In an embodiment, the electron transport region may include a compound represented by Formula 601:

[Ar.sub.601].sub.xe11−[(L.sub.601).sub.xe1-R.sub.601].sub.xe21   Formula 601

[0304] wherein, in Formula 601,

[0305] Ar601 and L.sub.601 may each independently be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a,

[0306] xe11 may be 1, 2, or 3,

[0307] xe1 may be 0, 1, 2, 3, 4, or 5,

[0308] R.sub.601 may be a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, —SI(Q.sub.601)(Q.sub.602)(Q.sub.603), —C(═O)(Q.sub.601), —S(═O).sub.2(Q.sub.601), or —P(═O)(Q.sub.601)(Q.sub.602),

[0309] Q.sub.601 to Q.sub.603 may each independently be the same as described in connection with Q.sub.1,

[0310] xe21 may be 1, 2, 3, 4, or 5, and

[0311] at least one of Ar.sub.601, L.sub.601, and R.sub.601 may each independently be a π electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group unsubstituted or substituted with at least one R.sub.10a.

[0312] For example, when xe11 in Formula 601 is 2 or more, two or more of Ar.sub.601(s) may be linked to each other via a single bond.

[0313] In one or more embodiments, Ar.sub.601 in Formula 601 may be a substituted or unsubstituted anthracene group.

[0314] In one or more embodiments, the electron transport region may include a compound represented by Formula 601-1:

##STR00118##

[0315] wherein, in Formula 601-1,

[0316] X.sub.614 may be N or C(R.sub.614), X.sub.615 may be N or C(R.sub.615), X.sub.616 may be N or C(R.sub.616), and at least one of X.sub.614 to X.sub.616 may be N,

[0317] L.sub.611 to L.sub.613 may each independently be the same as described in connection with L.sub.601,

[0318] xe611 to xe613 may each independently be the same as described in connection with xe1,

[0319] R.sub.611 to R.sub.613 may each independently be the same as described in connection with R.sub.601, and

[0320] R.sub.614 to R.sub.616 may each independently be hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a.

[0321] For example, xe1 and xe611 to xe613 in Formulae 601 and 601-1 may each independently be 0, 1, or 2.

[0322] The electron transport region may include at least one of Compounds ET1 to ET45, 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), 4,7-diphenyl-1,10-phenanthroline (Bphen), Alq.sub.3, BAlq, TAZ, NTAZ, or any combination thereof:

##STR00119## ##STR00120## ##STR00121## ##STR00122## ##STR00123## ##STR00124## ##STR00125##

[0323] A thickness of the electron transport region may be in a range of about 100 Å to about 5,000 Å, for example, about 160 Å to about 4,000 Å. When the electron transport region includes a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, or any combination thereof, a thickness of the buffer layer, the hole blocking layer, or the electron control layer may each independently be in a range of about 20 Å to about 1,000 Å, for example, about 30 Å to about 300 Å, and a thickness of the electron transport layer may be in a range of about 100 A to about 1,000 Å, for example, about 150 Å to about 500 Å. When the thicknesses of the buffer layer, the hole blocking layer, the electron control layer, the electron transport layer, and/or the electron transport region are within these ranges, satisfactory electron transporting characteristics may be obtained without a substantial increase in driving voltage.

[0324] The electron transport region (for example, the electron transport layer in the electron transport region) may further include, in addition to the materials described above, a metal-containing material.

[0325] The metal-containing material may include an alkali metal complex, an alkaline earth metal complex, or any combination thereof. A metal ion of the alkali metal complex may be a Li ion, a Na ion, a K ion, a Rb ion, or a Cs ion, and a metal ion of the alkaline earth metal complex may be a Be ion, a Mg ion, a Ca ion, a Sr ion, or a Ba ion. A ligand coordinated with the metal ion of the alkali metal complex or the alkaline earth-metal complex may include hydroxyquinoline, hydroxyisoquinoline, hydroxybenzoquinoline, hydroxyacridine, hydroxyphenanthridine, hydroxyphenyloxazole, hydroxyphenylthiazole, hydroxyphenyloxadiazole, hydroxyphenylthiadiazole, hydroxyphenylpyridine, hydroxyphenylbenzimidazole, hydroxyphenylbenzothiazole, bipyridine, phenanthroline, cyclopentadiene, or any combination thereof.

[0326] For example, the metal-containing material may include a Li complex. The Li complex may include, for example, Compound ET-D1 (LiQ) or ET-D2:

##STR00126##

[0327] The electron transport region may include an electron injection layer that facilitates the injection of electrons from the second electrode 150. The electron injection layer may be in direct contact with the second electrode 150.

[0328] The electron injection layer may have i) a single-layered structure consisting of a single layer consisting of a single material, ii) a single-layered structure consisting of a single layer including (e.g., consisting of) a plurality of different materials, or iii) a multi-layered structure including a plurality of layers including different materials.

[0329] The electron injection layer may include an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal-containing compound, an alkaline earth metal-containing compound, a rare earth metal-containing compound, an alkali metal complex, an alkaline earth metal complex, a rare earth metal complex, or any combination thereof.

[0330] The alkali metal may include Li, Na, K, Rb, Cs, or any combination thereof. The alkaline earth metal may include Mg, Ca, Sr, Ba, or any combination thereof. The rare earth metal may include Sc, Y, Ce, Tb, Yb, Gd, or any combination thereof.

[0331] The alkali metal-containing compound, the alkaline earth metal-containing compound, and the rare earth metal-containing compound may be one or more oxides, halides (for example, fluorides, chlorides, bromides, iodides, etc.), and/or tellurides of the alkali metal, the alkaline earth metal, and the rare earth metal, or any combination thereof.

[0332] The alkali metal-containing compound may include: one or more alkali metal oxides, such as Li.sub.2O, Cs.sub.2O, and/or K.sub.2O; alkali metal halides, such as LiF, NaF, CsF, KF, Lil, Nal, CsI, and/or KI; or any combination thereof. The alkaline earth metal-containing compound may include an alkaline earth metal compound, such as BaO, SrO, CaO, Ba.sub.xSr.sub.1−xO (wherein x is a real number satisfying the condition of 0<x<1), and/or Ba.sub.xCa.sub.1−xO (wherein x is a real number satisfying the condition of 0<x<1). The rare earth metal-containing compound may include YbF.sub.3, ScF.sub.3, Sc.sub.2O.sub.3, Y.sub.2O.sub.3, Ce.sub.2O.sub.3, GdF.sub.3, TbF.sub.3, YbI.sub.3, ScI.sub.3, TbI.sub.3, or any combination thereof. In one or more embodiments, the rare earth metal-containing compound may include lanthanide metal telluride. Examples of the lanthanide metal telluride may include LaTe, CeTe, PrTe, NdTe, PmTe, SmTe, EuTe, GdTe, TbTe, DyTe, HoTe, ErTe, TmTe, YbTe, LuTe, La.sub.2Te.sub.3, Ce.sub.2Te.sub.3, Pr.sub.2Te.sub.3, Nd.sub.2Te.sub.3, Pm.sub.2Te.sub.3, Sm.sub.2Te.sub.3, Eu.sub.2Te.sub.3, Gd.sub.2Te.sub.3, Tb.sub.2Te.sub.3, Dy.sub.2Te.sub.3, Ho.sub.2Te.sub.3, Er.sub.2Te.sub.3, Tm.sub.2Te.sub.3, Yb.sub.2Te.sub.3, and Lu.sub.2Te.sub.3.

[0333] The alkali metal complex, the alkaline earth-metal complex, and the rare earth metal complex may include i) one of ions of the alkali metal, the alkaline earth metal, and the rare earth metal and ii), as a ligand bonded to the metal ion, for example, hydroxyquinoline, hydroxyisoquinoline, hydroxybenzoquinoline, hydroxyacridine, hydroxyphenanthridine, hydroxyphenyloxazole, hydroxyphenylthiazole, hydroxyphenyloxadiazole, hydroxyphenylthiadiazole, hydroxyphenylpyridine, hydroxyphenyl benzimidazole, hydroxyphenylbenzothiazole, bipyridine, phenanthroline, cyclopentadiene, or any combination thereof.

[0334] The electron injection layer may include (e.g., consist of) an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal-containing compound, an alkaline earth metal-containing compound, a rare earth metal-containing compound, an alkali metal complex, an alkaline earth metal complex, a rare earth metal complex, or any combination thereof, as described above. In one or more embodiments, the electron injection layer may further include an organic material (for example, a compound represented by Formula 601).

[0335] In an embodiment, the electron injection layer may include (e.g., consist of) i) an alkali metal-containing compound (for example, an alkali metal halide), or ii) a) an alkali metal-containing compound (for example, an alkali metal halide); and b) an alkali metal, an alkaline earth metal, a rare earth metal, or any combination thereof. For example, the electron injection layer may be a KI:Yb co-deposited layer, an RbI:Yb co-deposited layer, a LiF:Yb co-deposited layer, and/or the like.

[0336] When the electron injection layer further includes an organic material, the alkali metal, the alkaline earth metal, the rare earth metal, the alkali metal-containing compound, the alkaline earth metal-containing compound, the rare earth metal-containing compound, the alkali metal complex, the alkaline earth-metal complex, the rare earth metal complex, or any combination thereof may be uniformly or non-uniformly dispersed in a matrix including the organic material.

[0337] A thickness of the electron injection layer may be in a range of about 1 Å to about 100 Å, for example, about 3 Å to about 90 Å. When the thickness of the electron injection layer is within these ranges, satisfactory electron injection characteristics may be obtained without a substantial increase in driving voltage.

Second Electrode 150

[0338] The second electrode 150 is disposed on the interlayer 130 as described above. The second electrode 150 may be a cathode, which is an electron injection electrode, and as a material for forming the second electrode 150, a metal, an alloy, an electrically conductive compound, or any combination thereof, each having a low work function, may be utilized.

[0339] The second electrode 150 may include lithium (Li), silver (Ag), magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), magnesium-silver (Mg—Ag), ytterbium (Yb), silver-ytterbium (Ag—Yb), ITO, IZO, or any combination thereof. The second electrode 150 may be a transmissive electrode, a semi-transmissive electrode, or a reflective electrode.

[0340] The second electrode 150 may have a single-layered structure or a multi-layered structure including a plurality of layers.

Capping Layer

[0341] A first capping layer may be located outside the first electrode 110 (e.g., on the side of the first electrode 110 facing oppositely away from the second electrode 150), and/or a second capping layer may be located outside the second electrode 150 (e.g., on the side of the second electrode 150 facing oppositely away from the first electrode 110). In one or embodiments, the light-emitting device 10 may have a structure in which the first capping layer, the first electrode 110, the interlayer 130, and the second electrode 150 are sequentially stacked in the stated order, a structure in which the first electrode 110, the interlayer 130, the second electrode 150, and the second capping layer are sequentially stacked in the stated order, or a structure in which the first capping layer, the first electrode 110, the interlayer 130, the second electrode 150, and the second capping layer are sequentially stacked in the stated order.

[0342] Light generated in the emission layer of the interlayer 130 of the light-emitting device 10 may be extracted (e.g., emitted) toward the outside through the first electrode 110, which is a semi-transmissive electrode or a transmissive electrode, and the first capping layer, or, light generated in the emission layer of the interlayer 130 of the light-emitting device 10 may be extracted (e.g., emitted) toward the outside through the second electrode 150, which is a semi-transmissive electrode or a transmissive electrode, and the second capping layer.

[0343] The first capping layer and the second capping layer may increase external luminescence efficiency according to the principle of constructive interference. Accordingly, the light extraction efficiency of the light-emitting device 10 may be increased, so that the luminescence efficiency of the light-emitting device 10 may be improved.

[0344] Each of the first capping layer and the second capping layer may include a material having a refractive index of 1.6 or more (at a wavelength of 589 nm).

[0345] The first capping layer and the second capping layer may each independently be an organic capping layer including an organic material, an inorganic capping layer including an inorganic material, or an organic-inorganic composite capping layer including an organic material and an inorganic material.

[0346] At least one of the first capping layer or the second capping layer may each independently include a carbocyclic compound, a heterocyclic compound, an amine group-containing compound, a porphine derivative, a phthalocyanine derivative, a naphthalocyanine derivative, an alkali metal complex, an alkaline earth metal complex, or any combination thereof. The carbocyclic compound, the heterocyclic compound, and the amine group-containing compound may optionally be substituted with a substituent including O, N, S, Se, Si, F, Cl, Br, I, or any combination thereof. In an embodiment, at least one of the first capping layer or the second capping layer may each independently include an amine group-containing compound.

[0347] In one or more embodiments, at least one of the first capping layer or the second capping layer may each independently include a compound represented by Formula 201, a compound represented by Formula 202, or any combination thereof.

[0348] In one or more embodiments, at least one of the first capping layer or the second capping layer may each independently include at least one of Compounds HT28 to HT33, at least one of Compounds CP1 to CP6, β-NPB, or any combination thereof:

##STR00127##

Film

[0349] The organometallic compound represented by Formula 1 may be included in one or more suitable films. Accordingly, another aspect of the present disclosure provides a film including the organometallic compound represented by Formula 1. The film may be, for example, an optical member (or a light control means) (for example, a color filter, a color conversion member, a capping layer, a light extraction efficiency enhancement layer, a selective light absorbing layer, a polarizing layer, a quantum dot-containing layer, etc.), a light-blocking member (for example, a light reflective layer, a light absorbing layer, etc.), and/or a protective member (for example, an insulating layer, a dielectric layer, etc.).

Electronic Apparatus

[0350] The light-emitting device may be included in one or more suitable electronic apparatuses. For example, the electronic apparatus including the light-emitting device may be a light-emitting apparatus, an authentication apparatus, and/or the like.

[0351] The electronic apparatus (for example, a light-emitting apparatus) may further include, in addition to the light-emitting device, i) a color filter, ii) a color conversion layer, or iii) a color filter and a color conversion layer. The color filter and/or the color conversion layer may be located in at least one traveling direction of light emitted from the light-emitting device. For example, the light emitted from the light-emitting device may be blue light or white light. The light-emitting device is the same as described above. In an embodiment, the color conversion layer may include a quantum dot. The quantum dot may be, for example, a quantum dot as described herein.

[0352] The electronic apparatus may include a first substrate. The first substrate may include a plurality of subpixel areas, the color filter may include a plurality of color filter areas respectively corresponding to the plurality of subpixel areas, and the color conversion layer may include a plurality of color conversion areas respectively corresponding to the plurality of subpixel areas.

[0353] A pixel defining film may be located among the plurality of subpixel areas to define each of the subpixel areas.

[0354] The color filter may further include a plurality of color filter areas and light-shielding patterns located among the plurality of color filter areas, and the color conversion layer may further include a plurality of color conversion areas and light-shielding patterns located among the plurality of color conversion areas.

[0355] The plurality of color filter areas (or the plurality of color conversion areas) may include a first area emitting a first color light, a second area emitting second color light, and/or a third area emitting a third color light, and the first color light, the second color light, and/or the third color light may have different maximum emission wavelengths. For example, the first color light may be red light, the second color light may be green light, and the third color light may be blue light. For example, the plurality of color filter areas (or the plurality of color conversion areas) may include quantum dots. In an embodiment, the first area may include red quantum dots, the second area may include green quantum dots, and the third area may not include (e.g., may exclude) quantum dots. The quantum dot is the same as described herein. The first area, the second area, and/or the third area may each further include a scatterer.

[0356] In one or more embodiments, the light-emitting device may be to emit a first light, the first area may be to absorb the first light to emit a first-first color light, the second area may be to absorb the first light to emit a second-first color light, and the third area may be to absorb the first light to emit a third-first color light. In this regard, the first-first color light, the second-first color light, and the third-first color light may have different maximum emission wavelengths. For example, the first light may be blue light, the first-first color light may be red light, the second-first color light may be green light, and the third-first color light may be blue light.

[0357] The electronic apparatus may further include a thin-film transistor, in addition to the light-emitting device as described above. The thin-film transistor may include a source electrode, a drain electrode, and an activation layer, wherein the source electrode or the drain electrode may be electrically connected to the first electrode or the second electrode of the light-emitting device.

[0358] The thin-film transistor may further include a gate electrode, a gate insulating film, and/or the like.

[0359] The activation layer may include crystalline silicon, amorphous silicon, an organic semiconductor, an oxide semiconductor, and/or the like.

[0360] The electronic apparatus may further include a sealing portion for sealing the light-emitting device. The sealing portion may be located between the color filter and/or the color conversion layer and the light-emitting device. The sealing portion allows light from the light-emitting device to be extracted to the outside, and concurrently (e.g., simultaneously) prevents or reduces penetration of ambient air and/or moisture into the light-emitting device. The sealing portion may be a sealing substrate including a transparent glass substrate and/or a plastic substrate. The sealing portion may be a thin-film encapsulation layer including at least one layer of an organic layer and/or an inorganic layer. When the sealing portion is a thin-film encapsulating layer, the electronic apparatus may be flexible.

[0361] Various suitable functional layers may be additionally disposed on the sealing portion, in addition to the color filter and/or the color conversion layer, according to the usage of the electronic apparatus. The functional layers may include a touch screen layer, a polarizing layer, and/or the like. The touch screen layer may be a pressure-sensitive touch screen layer, a capacitive touch screen layer, or an infrared touch screen layer.

[0362] The authentication apparatus may further include, in addition to the light-emitting device as described above, a biometric information collector. The authentication apparatus may be, for example, a biometric authentication apparatus that authenticates an individual by utilizing biometric information of a living body (for example, fingertips, pupils, etc.).

[0363] The electronic apparatus may be applied to one or more suitable displays, light sources, lighting apparatuses, personal computers (for example, a mobile personal computer), mobile phones, digital cameras, electronic organizers, electronic dictionaries, electronic game machines, medical instruments (for example, electronic thermometers, sphygmomanometers, blood glucose meters, pulse measurement devices, pulse wave measurement devices, electrocardiogram displays, ultrasonic diagnostic devices, and/or endoscope displays), fish finders, one or more suitable measuring instruments, meters (for example, meters for a vehicle, an aircraft, and/or a vessel), projectors, and/or the like.

Description of FIGS. 2 and 3

[0364] FIG. 2 is a cross-sectional view of a light-emitting apparatus 180 according to an embodiment.

[0365] The light-emitting apparatus 180 of FIG. 2 includes a substrate 100, a thin-film transistor (TFT), a light-emitting device, and an encapsulation portion 300 that seals the light-emitting device.

[0366] The substrate 100 may be a flexible substrate, a glass substrate, or a metal substrate. A buffer layer 210 may be disposed on the substrate 100. The buffer layer 210 may prevent or reduce penetration of impurities through the substrate 100 and may provide a flat surface on the substrate 100.

[0367] The TFT may be disposed on the buffer layer 210. The TFT may include an activation layer 220, a gate electrode 240, a source electrode 260, and a drain electrode 270.

[0368] The activation layer 220 may include an inorganic semiconductor such as silicon and/or polysilicon, an organic semiconductor, and/or an oxide semiconductor, and may include a source region, a drain region, and a channel region.

[0369] A gate insulating film 230 for insulating the activation layer 220 from the gate electrode 240 may be disposed on the activation layer 220, and the gate electrode 240 may be disposed on the gate insulating film 230.

[0370] An interlayer insulating film 250 may be disposed on the gate electrode 240. The interlayer insulating film 250 may be located between the gate electrode 240 and the source electrode 260 to insulate the gate electrode 240 from the source electrode 260 and between the gate electrode 240 and the drain electrode 270 to insulate the gate electrode 240 from the drain electrode 270.

[0371] The source electrode 260 and the drain electrode 270 may be disposed on the interlayer insulating film 250. The interlayer insulating film 250 and the gate insulating film 230 may be formed to expose the source region and the drain region of the activation layer 220, and the source electrode 260 and the drain electrode 270 may be located in contact with the exposed portions of the source region and the drain region of the activation layer 220.

[0372] The TFT is electrically connected to a light-emitting device to drive the light-emitting device, and is covered and protected by a passivation layer 280. The passivation layer 280 may include an inorganic insulating film, an organic insulating film, or any combination thereof. A light-emitting device is provided on the passivation layer 280. The light-emitting device may include a first electrode 110, an interlayer 130, and a second electrode 150.

[0373] The first electrode 110 may be disposed on the passivation layer 280. The passivation layer 280 may be located to expose a certain region of the drain electrode 270 without fully covering the drain electrode 270, and the first electrode 110 may be located to be connected to the exposed region of the drain electrode 270.

[0374] A pixel defining layer 290 including an insulating material may be disposed on the first electrode 110. The pixel defining layer 290 may expose a certain region of the first electrode 110, and the interlayer 130 may be formed in the exposed region of the first electrode 110. The pixel defining layer 290 may be a polyimide or polyacrylic organic film. In one embodiment, one or more layers of the interlayer 130 may extend beyond the upper portion of the pixel defining layer 290 in the form of a common layer.

[0375] The second electrode 150 may be disposed on the interlayer 130, and a capping layer 170 may be additionally formed on the second electrode 150. The capping layer 170 may be formed to cover the second electrode 150.

[0376] The encapsulation portion 300 may be disposed on the capping layer 170. The encapsulation portion 300 may be disposed on a light-emitting device to protect the light-emitting device from moisture and/or oxygen. The encapsulation portion 300 may include: an inorganic film including silicon nitride (SiNx), silicon oxide (SiOx), indium tin oxide, indium zinc oxide, or any combination thereof; an organic film including polyethylene terephthalate, polyethylene naphthalate, polycarbonate, polyimide, polyethylene sulfonate, polyoxymethylene, polyarylate, hexamethyldisiloxane, an acrylic resin (for example, polymethyl methacrylate, polyacrylic acid, etc.), an epoxy-based resin (for example, aliphatic glycidyl ether (AGE), etc.), or any combination thereof; or a combination of the inorganic film and the organic film.

[0377] FIG. 3 is a cross-sectional view of a light-emitting apparatus 190 according to another embodiment.

[0378] The light-emitting apparatus 190 of FIG. 3 is the same as the light-emitting apparatus 180 of FIG. 2, except that a light-shielding pattern 500 and a functional region 400 are additionally disposed on the encapsulation portion 300. The functional region 400 may be i) a color filter area, ii) a color conversion area, or iii) a combination of the color filter area and the color conversion area. In an embodiment, the light-emitting device included in the light-emitting apparatus 190 of FIG. 3 may be a tandem light-emitting device.

Manufacturing Method

[0379] The layers included in the hole transport region, the emission layer, and the layers included in the electron transport region may be formed in a certain region by utilizing one or more suitable methods such as vacuum deposition, spin coating, casting, Langmuir-Blodgett (LB) deposition, ink-jet printing, laser-printing, laser-induced thermal imaging, and/or the like.

[0380] When the layers included in the hole transport region, the emission layer, and the layers included in the electron transport region are formed by vacuum deposition, the vacuum deposition may be performed at a deposition temperature of about 100° C. to about 500° C., a vacuum degree of about 10.sup.−8 torr to about 10.sup.−3 torr, and a deposition speed of about 0.01 Å/sec to about 100 Å/sec, depending on a material to be included in a layer to be formed and the structure of a layer to be formed.

Definition of Terms

[0381] The term “C.sub.3-C.sub.60 carbocyclic group” as used herein refers to a cyclic group consisting of only carbon atoms as ring-forming atoms and having 3 to 60 carbon atoms, and the term “C.sub.1-C.sub.60 heterocyclic group” as used herein refers to a cyclic group that has, in addition to 1 to 60 carbon atoms, a heteroatom as a ring-forming atom. The C.sub.3-C.sub.60 carbocyclic group and the C.sub.1-C.sub.60 heterocyclic group may each be a monocyclic group consisting of one ring or a polycyclic group in which two or more rings are condensed with each other. For example, the C.sub.1-C.sub.60 heterocyclic group may have 3 to 61 ring-forming atoms.

[0382] The term “cyclic group” as used herein may include both the C.sub.3-C.sub.60 carbocyclic group and the C.sub.1-C.sub.60 heterocyclic group.

[0383] The term “π electron-rich C.sub.3-C.sub.60 cyclic group” as used herein refers to a cyclic group that has 3 to 60 carbon atoms and does not include *—N=*′ as a ring-forming moiety. The term “π electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group” as used herein refers to a heterocyclic group that has 1 to 60 carbon atoms and includes *—N═*′ as a ring-forming moiety.

[0384] For example,

[0385] the C.sub.3-C.sub.60 carbocyclic group may be i) a T1 group or ii) a condensed cyclic group in which at least two T1 groups are condensed with each other (for example, the C.sub.3-C.sub.60 carbocyclic group may be a cyclopentadiene group, an adamantane group, a norbornane group, a benzene group, a pentalene group, a naphthalene group, an azulene group, an indacene group, an acenaphthylene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a perylene group, a pentaphene group, a heptalene group, a naphthacene group, a picene group, a hexacene group, a pentacene group, a rubicene group, a coronene group, an ovalene group, an indene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, an indenophenanthrene group, or an indenoanthracene group),

[0386] the C.sub.1-C.sub.60 heterocyclic group may be i) a T2 group, ii) a condensed cyclic group in which at least two T2 groups are condensed with each other, or iii) a condensed cyclic group in which at least one T2 group and at least one T1 group are condensed with each other (for example, the C.sub.1-C.sub.60 heterocyclic group may be a pyrrole group, a thiophene group, a furan group, an indole group, a benzoindole group, a naphthoindole group, an isoindole group, a benzoisoindole group, a naphthoisoindole group, a benzosilole group, a benzothiophene group, a benzofuran group, a carbazole group, a dibenzosilole group, a dibenzothiophene group, a dibenzofuran group, an indenocarbazole group, an indolocarbazole group, a benzofurocarbazole group, a benzothienocarbazole group, a benzosilolocarbazole group, a benzoindolocarbazole group, a benzocarbazole group, a benzonaphthofuran group, a benzonaphthothiophene group, a benzonaphthosilole group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienodibenzothiophene group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzoisoxazole group, a benzothiazole group, a benzoisothiazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a benzoisoquinoline group, a quinoxaline group, a benzoquinoxaline group, a quinazoline group, a benzoquinazoline group, a phenanthroline group, a cinnoline group, a phthalazine group, a naphthyridine group, an imidazopyridine group, an imidazopyrimidine group, an imidazotriazine group, an imidazopyrazine group, an imidazopyridazine group, an azacarbazole group, an azafluorene group, an azadibenzosilole group, an azadibenzothiophene group, an azadibenzofuran group, etc.),

[0387] the π electron-rich C.sub.3-C.sub.60 cyclic group may be i) a T1 group, ii) a condensed cyclic group in which at least two T1 groups are condensed with each other, iii) a T3 group, iv) a condensed cyclic group in which at least two T3 groups are condensed with each other, or v) a condensed cyclic group in which at least one T3 group and at least one T1 group are condensed with each other (for example, the π electron-rich C.sub.3-C.sub.60 cyclic group may be the C.sub.3-C.sub.60 carbocyclic group, a 1H-pyrrole group, a silole group, a borole group, a 2H-pyrrole group, a 3H-pyrrole group, a thiophene group, a furan group, an indole group, a benzoindole group, a naphthoindole group, an isoindole group, a benzoisoindole group, a naphthoisoindole group, a benzosilole group, a benzothiophene group, a benzofuran group, a carbazole group, a dibenzosilole group, a dibenzothiophene group, a dibenzofuran group, an indenocarbazole group, an indolocarbazole group, a benzofurocarbazole group, a benzothienocarbazole group, a benzosilolocarbazole group, a benzoindolocarbazole group, a benzocarbazole group, a benzonaphthofuran group, a benzonaphthothiophene group, a benzonaphthosilole group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienodibenzothiophene group, etc.),

[0388] the π electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group may be i) a T4 group, ii) a condensed cyclic group in which at least two T4 groups are condensed with each other, iii) a condensed cyclic group in which at least one T4 group and at least one T1 group are condensed with each other, iv) a condensed cyclic group in which at least one T4 group and at least one T3 group are condensed with each other, or v) a condensed cyclic group in which at least one T4 group, at least one T1 group, and at least one T3 group are condensed with one another (for example, the π electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group may be a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzoisoxazole group, a benzothiazole group, a benzoisothiazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a benzoisoquinoline group, a quinoxaline group, a benzoquinoxaline group, a quinazoline group, a benzoquinazoline group, a phenanthroline group, a cinnoline group, a phthalazine group, a naphthyridine group, an imidazopyridine group, an imidazopyrimidine group, an imidazotriazine group, an imidazopyrazine group, an imidazopyridazine group, an azacarbazole group, an azafluorene group, an azadibenzosilole group, an azadibenzothiophene group, an azadibenzofuran group, etc.),

[0389] the T1 group may be a cyclopropane group, a cyclobutane group, a cyclopentane group, a cyclohexane group, a cycloheptane group, a cyclooctane group, a cyclobutene group, a cyclopentene group, a cyclopentadiene group, a cyclohexene group, a cyclohexadiene group, a cycloheptene group, an adamantane group, a norbornane (or a bicyclo[2.2.1]heptane) group, a norbornene group, a bicyclo[1.1.1]pentane group, a bicyclo[2.1.1]hexane group, a bicyclo[2.2.2]octane group, or a benzene group,

[0390] the T2 group may be a furan group, a thiophene group, a 1H-pyrrole group, a silole group, a borole group, a 2H-pyrrole group, a 3H-pyrrole group, an imidazole group, a pyrazole group, a triazole group, a tetrazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, an azasilole group, an azaborole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a tetrazine group, a pyrrolidine group, an imidazolidine group, a dihydropyrrole group, a piperidine group, a tetrahydropyridine group, a dihydropyridine group, a hexahydropyrimidine group, a tetrahydropyrimidine group, a dihydropyrimidine group, a piperazine group, a tetrahydropyrazine group, a dihydropyrazine group, a tetrahydropyridazine group, or a dihydropyridazine group,

[0391] the T3 group may be a furan group, a thiophene group, a 1H-pyrrole group, a silole group, or a borole group, and

[0392] the T4 group may be a 2H-pyrrole group, a 3H-pyrrole group, an imidazole group, a pyrazole group, a triazole group, a tetrazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, an azasilole group, an azaborole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, or a tetrazine group.

[0393] The terms “the cyclic group,” “the C.sub.3-C.sub.60 carbocyclic group,” “the C.sub.1-C.sub.60 heterocyclic group,” “the π electron-rich C.sub.3-C.sub.60 cyclic group,” or “the π electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group” as used herein each refer to a group condensed to (e.g., combined together with) any cyclic group, a monovalent group, or a polyvalent group (for example, a divalent group, a trivalent group, a tetravalent group, etc.) according to the structure of a formula for which the corresponding term is used. For example, the “benzene group” may be a benzo group, a phenyl group, a phenylene group, and/or the like, which may be easily understood by one of ordinary skill in the art according to the structure of a formula including the “benzene group.”

[0394] Examples of the monovalent C.sub.3-C.sub.60 carbocyclic group and the monovalent C.sub.1-C.sub.60 heterocyclic group may include a C.sub.3-C.sub.10 cycloalkyl group, a C.sub.1-C.sub.10 heterocycloalkyl group, a C.sub.3-C.sub.10 cycloalkenyl group, a C.sub.1-C.sub.10 heterocycloalkenyl group, a C.sub.6-C.sub.60 aryl group, a C.sub.1-C.sub.60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, and examples of the divalent C.sub.3-C.sub.60 carbocyclic group and the divalent C.sub.1-C.sub.60 heterocyclic group may include a C.sub.3-C.sub.10 cycloalkylene group, a C.sub.1-C.sub.10 heterocycloalkylene group, a C.sub.3-C.sub.10 cycloalkenylene group, a C.sub.1-C.sub.10 heterocycloalkenylene group, a C.sub.6-C.sub.60 arylene group, a C.sub.1-C.sub.60 heteroarylene group, a divalent non-aromatic condensed polycyclic group, and a divalent non-aromatic condensed heteropolycyclic group.

[0395] The term “C.sub.1-C.sub.60 alkyl group” as used herein refers to a linear or branched aliphatic hydrocarbon monovalent group that has 1 to 60 carbon atoms, and examples thereof may include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a sec-butyl group, an isobutyl group, a tert-butyl group, an n-pentyl group, a tert-pentyl group, a neopentyl group, an isopentyl group, a sec-pentyl group, a 3-pentyl group, a sec-isopentyl group, an n-hexyl group, an isohexyl group, a sec-hexyl group, a tert-hexyl group, an n-heptyl group, an isoheptyl group, a sec-heptyl group, a tert-heptyl group, an n-octyl group, an isooctyl group, a sec-octyl group, a tert-octyl group, an n-nonyl group, an isononyl group, a sec-nonyl group, a tert-nonyl group, an n-decyl group, an isodecyl group, a sec-decyl group, and a tert-decyl group. The term “C.sub.1-C.sub.60 alkylene group” as used herein refers to a divalent group having substantially the same structure as the C.sub.1-C.sub.60 alkyl group.

[0396] The term “C.sub.2-C.sub.60 alkenyl group” as used herein refers to a monovalent hydrocarbon group having at least one carbon-carbon double bond at a main chain (e.g., in the middle) and/or at a terminal end (e.g., the terminus) of the C.sub.2-C.sub.60 alkyl group, and examples thereof may include an ethenyl group, a propenyl group, and a butenyl group. The term “C.sub.2-C.sub.60 alkenylene group” as used herein refers to a divalent group having substantially the same structure as the C.sub.2-C.sub.60 alkenyl group.

[0397] The term “C.sub.2-C.sub.60 alkynyl group” as used herein refers to a monovalent hydrocarbon group having at least one carbon-carbon triple bond at a main chain (e.g., in the middle) and/or at a terminal end (e.g., the terminus) of the C.sub.2-C.sub.60 alkyl group, and examples thereof may include an ethynyl group and a propynyl group. The term “C.sub.2-C.sub.60 alkynylene group” as used herein refers to a divalent group having substantially the same structure as the C.sub.2-C.sub.60 alkynyl group.

[0398] The term “C.sub.1-C.sub.60 alkoxy group” as used herein refers to a monovalent group represented by —OA.sub.101 (wherein Ani is the C.sub.1-C.sub.60 alkyl group), and examples thereof may include a methoxy group, an ethoxy group, and an isopropyloxy group.

[0399] The term “C.sub.3-C.sub.10 cycloalkyl group” as used herein refers to a monovalent saturated hydrocarbon cyclic group having 3 to 10 carbon atoms, and examples thereof may include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group (or a bicyclo[2.2.1]heptyl group), a bicyclo[1.1.1]pentyl group, a bicyclo[2.1.1]hexyl group, and a bicyclo[2.2.2]octyl group. The term “C.sub.3-C.sub.10 cycloalkylene group” as used herein refers to a divalent group having substantially the same structure as the C.sub.3-C.sub.10 cycloalkyl group.

[0400] The term “C.sub.1-C.sub.10 heterocycloalkyl group” as used herein refers to a monovalent saturated monocyclic group that includes, in addition to 1 to 10 carbon atoms, at least one heteroatom, as ring-forming atoms, and examples thereof may include a 1,2,3,4-oxatriazolidinyl group, a tetrahydrofuranyl group, and a tetrahydrothiophenyl group. The term “C.sub.1-C.sub.10 heterocycloalkylene group” as used herein refers to a divalent group having substantially the same structure as the C.sub.1-C.sub.10 heterocycloalkyl group.

[0401] The term “C.sub.3-C.sub.10 cycloalkenyl group” as used herein refers to a monovalent cyclic group that has 3 to 10 carbon atoms and at least one carbon-carbon double bond in the ring thereof and no aromaticity, and examples thereof may include a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. The term “C.sub.3-C.sub.10 cycloalkenylene group” as used herein refers to a divalent group having substantially the same structure as the C.sub.3-C.sub.10 cycloalkenyl group.

[0402] The term “C.sub.1-C.sub.10 heterocycloalkenyl group” as used herein refers to a monovalent cyclic group that includes, in addition to 1 to 10 carbon atoms, at least one heteroatom, as ring-forming atoms, and having at least one carbon-carbon double bond in the cyclic structure thereof. Examples of the C.sub.1-C.sub.10 heterocycloalkenyl group may include a 4,5-dihydro-1,2,3,4-oxatriazolyl group, a 2,3-dihydrofuranyl group, and a 2,3-dihydrothiophenyl group. The term “C.sub.1-C.sub.10 heterocycloalkenylene group” as used herein refers to a divalent group having substantially the same structure as the C.sub.1-C.sub.10 heterocycloalkenyl group.

[0403] The term “C.sub.6-C.sub.60 aryl group” as used herein refers to a monovalent group having a carbocyclic aromatic system of 6 to 60 carbon atoms, and the term “C.sub.6-C.sub.60 arylene group” as used herein refers to a divalent group having a carbocyclic aromatic system of 6 to 60 carbon atoms. Examples of the C.sub.6-C.sub.60 aryl group may include a phenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, an indacenyl group, an acenaphthyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a heptalenyl group, a naphthacenyl group, a picenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, a fluorenyl group, and an ovalenyl group. When the C.sub.6-C.sub.60 aryl group and the C.sub.6-C.sub.60 arylene group each include two or more rings, the two or more rings may be condensed with each other.

[0404] The term “C.sub.1-C.sub.60 heteroaryl group” as used herein refers to a monovalent group having a heterocyclic aromatic system that has, in addition to 1 to 60 carbon atoms, at least one heteroatom, as ring-forming atoms. The term “C.sub.1-C.sub.60 heteroarylene group” as used herein refers to a divalent group having a heterocyclic aromatic system that has, in addition to 1 to 60 carbon atoms, at least one heteroatom, as ring-forming atoms. Examples of the C.sub.1-C.sub.60 heteroaryl group may include a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, a benzoquinolinyl group, an isoquinolinyl group, a benzoisoquinolinyl group, a quinoxalinyl group, a benzoquinoxalinyl group, a quinazolinyl group, a benzoquinazolinyl group, a cinnolinyl group, a phenanthrolinyl group, a phthalazinyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiofuranyl group, and a naphthyridinyl group. When the C.sub.1-C.sub.60 heteroaryl group and the C.sub.1-C.sub.60 heteroarylene group each include two or more rings, the two or more rings may be condensed with each other.

[0405] The term “monovalent non-aromatic condensed polycyclic group” as used herein refers to a monovalent group having two or more rings condensed to each other, only carbon atoms (for example, having 8 to 60 carbon atoms) as ring-forming atoms, and no aromaticity in its entire molecular structure (e.g., is not aromatic when considered as a whole). Examples of the monovalent non-aromatic condensed polycyclic group may include an indenyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, an indenophenanthrenyl group, an adamantyl group, and an indenoanthracenyl group. The term “divalent non-aromatic condensed polycyclic group” as used herein refers to a divalent group having substantially the same structure as the monovalent non-aromatic condensed polycyclic group.

[0406] The term “monovalent non-aromatic condensed heteropolycyclic group” as used herein refers to a monovalent group having two or more rings condensed to each other, in addition to carbon atoms (for example, having 1 to 60 carbon atoms), further including at least one heteroatom, as ring-forming atoms, and having non-aromaticity in its entire molecular structure (e.g., is not aromatic when considered as a whole). Examples of the monovalent non-aromatic condensed heteropolycyclic group may include a pyrrolyl group, a thiophenyl group, a furanyl group, an indolyl group, a benzoindolyl group, a naphthoindolyl group, an isoindolyl group, a benzoisoindolyl group, a naphthoisoindolyl group, a benzosilolyl group, a benzothiophenyl group, a benzofuranyl group, a dibenzosilolyl group, a dibenzothiophenyl group, a dibenzofuranyl group, an azacarbazolyl group, an azafluorenyl group, an azadibenzosilolyl group, an azadibenzothiophenyl group, an azadibenzofuranyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, a thiadiazolyl group, a benzopyrazolyl group, a benzimidazolyl group, a benzoxazolyl group, a benzothiazolyl group, a benzoxadiazolyl group, a benzothiadiazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an imidazotriazinyl group, an imidazopyrazinyl group, an imidazopyridazinyl group, an indeno carbazolyl group, an indolocarbazolyl group, a benzofurocarbazolyl group, a benzothienocarbazolyl group, a benzosilolocarbazolyl group, a benzoindolocarbazolyl group, a benzocarbazolyl group, a benzonaphthofuranyl group, a benzonaphthothiophenyl group, a benzonaphtho silolyl group, a benzofurodibenzofuranyl group, a benzofurodibenzothiophenyl group, an azaadamantyl group, and a benzothienodibenzothiophenyl group. The term “divalent non-aromatic condensed heteropolycyclic group” as used herein refers to a divalent group having substantially the same structure as the monovalent non-aromatic condensed heteropolycyclic group.

[0407] The term “C.sub.6-C.sub.60 aryloxy group” as used herein refers to a monovalent group represented by —OA.sub.102 (wherein A.sub.102 is the C.sub.6-C.sub.60 aryl group), and the term “C.sub.6-C.sub.60 arylthio group” as used herein refers to a monovalent group represented by —SA.sub.103 (wherein A.sub.103 is the C.sub.6-C.sub.60 aryl group).

[0408] The term “C.sub.7-C.sub.60 arylalkyl group” as used herein refers to a monovalent group represented by -A.sub.104A.sub.105 (wherein A.sub.104 is a C.sub.1-C.sub.54 alkylene group, and A.sub.105 is a C.sub.6-C.sub.59 aryl group), and the term “C.sub.2-C.sub.60 heteroarylalkyl group” as used herein refers to a monovalent group represented by -A.sub.106A.sub.107 (wherein A.sub.106 is a C.sub.1-C.sub.59 alkylene group, and A.sub.107 is a C.sub.1-C.sub.59 heteroaryl group).

[0409] The term “R.sub.10a” as used herein refers to:

[0410] deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group;

[0411] a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 arylalkyl group, a C.sub.2-C.sub.60 heteroarylalkyl group, —Si(Q.sub.11)(Q.sub.12)(Q.sub.13), —N(Q.sub.11)(Q.sub.12), —B(Q.sub.11)(Q.sub.12), —C(═O)(Q.sub.11), —S(═O).sub.2(Q.sub.11), —P(═O)(Q.sub.11)(Q.sub.12), or any combination thereof;

[0412] a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 aryl alkyl group, or a C.sub.2-C.sub.60 heteroaryl alkyl group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 aryl alkyl group, a C.sub.2-C.sub.60 heteroaryl alkyl group, —Si(Q.sub.21)(Q.sub.22)(Q.sub.23), —N(Q.sub.21)(Q.sub.22), —B(Q.sub.21)(Q.sub.22), —C(═O)(Q.sub.21), —S(═O).sub.2(Q.sub.21), —P(═O)(Q.sub.21)(Q.sub.22), or any combination thereof; or

[0413] —Si(Q.sub.31)(Q.sub.32)(Q.sub.33), —N(Q.sub.31)(Q.sub.32), —B(Q.sub.31)(Q.sub.32), —C(═O)(Q.sub.31), —S(═O).sub.2(Q.sub.31), or —P(═O)(Q.sub.31)(Q.sub.32).

[0414] Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 as used herein may each independently be: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, —F, a cyano group, or any combination thereof; a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof; a C.sub.7-C.sub.60 arylalkyl group; or a C.sub.2-C.sub.60 heteroarylalkyl group.

[0415] The term “heteroatom” as used herein refers to any atom other than a carbon atom. Examples of the heteroatom may include O, S, N, P, Si, B, Ge, Se, or any combination thereof.

[0416] The term “Ph” as used herein refers to a phenyl group, the term “Me” as used herein refers to a methyl group, the term “Et” as used herein refers to an ethyl group, the term “tert-Bu” or “But” as used herein refers to a tert-butyl group, and the term “OMe” as used herein refers to a methoxy group.

[0417] The term “biphenyl group” as used herein refers to “a phenyl group substituted with a phenyl group.” In other words, the “biphenyl group” is a substituted phenyl group having a C.sub.6-C.sub.60 aryl group as a substituent.

[0418] The term “terphenyl group” as used herein refers to “a phenyl group substituted with a biphenyl group.” In other words, the “terphenyl group” is a substituted phenyl group having, as a substituent, a C.sub.6-C.sub.60 aryl group substituted with a C.sub.6-C.sub.60 aryl group.

[0419] * and *′ as used herein, unless defined otherwise, each refer to a binding site to a neighboring atom in a corresponding formula or moiety.

[0420] Hereinafter, compounds according to embodiments and light-emitting devices according to embodiments will be described in more detail with reference to Synthesis Examples and Examples. The expression “B was used instead of A” used in describing Synthesis Examples refers to that an identical molar equivalent of B was used in place of A.

EXAMPLES

Synthesis Example 1: Synthesis of Compound D31

1. Synthesis of Intermediate Compound 31-3

[0421] ##STR00128##

[0422] Compound 31-2 (1.15 g, 4.15 mmol), Compound 31-1 (620 mg, 3.5 mmol), Pd(dppf)Cl.sub.2 (100 mg), and K.sub.2CCh (0.95 g, 6.9 mmol) were dissolved in dioxane (10 mL) and H.sub.2O (2 mL), and then heated at 110° C. under nitrogen gas for 6 hours. After cooling, H.sub.2O (10 mL) was added thereto, and an extraction process was performed thereon three times utilizing EtOAc (10 mL) to collect an organic layer, which was then dried over Na.sub.2SO.sub.4 and concentrated with a Rotavapor. The obtained solid was purified by high performance liquid chromatography (HPLC) to thereby obtain Intermediate Compound 31-3 (300 mg, yield of 25%).

2. Synthesis of Intermediate Compound 31-6

[0423] ##STR00129##

[0424] Pd(OAc).sub.2 (0.5 mol %), Pcy.sub.3 (1.0 mol %), Compound 31-4 (0.5 mmol), Compound 31-5 (0.75 mmol), K.sub.3PO.sub.4.Math.3H.sub.2O (3.0 eq.), and toluene (2.0 mL) were mixed in a sealed tube, and then heated at 80° C. under nitrogen gas for 10 minutes. After completion of the reaction, an organic layer was separated from the mixture utilizing ethyl acetate and water, and an aqueous layer was extracted from the mixture utilizing ethyl acetate. The separated organic layer was dried over Na.sub.2SO.sub.4, and purified and separated by chromatography utilizing silica gel to thereby obtain Intermediate Compound 31-6.

3. Synthesis of Intermediate Compound 31-7

[0425] ##STR00130##

[0426] 9-Borabicyclo[3.3.1]nonane (199.6 mL, 0.5 M in THF) was added to a N.sub.2-purged flask containing Intermediate Compound 31-6 (4.0 g, 16.3 mmol) and stirred at room temperature for 24 hours. Then, Compound 31-3 (7.5 g, 24.8 mmol), Ph.sub.3P (697.9 mg, 2.66 mmol), (Ph.sub.3P).sub.4Pd (384.3 mg, 0.33 mmol), and aq. 3N NaOH (13.7 mL) were added thereto. After stirring at 60° C. for 22 hours, the mixture was diluted with EtOAc (150 mL), and subjected to an extraction process three times utilizing aq. 1 N H.sub.2SO.sub.4 (200 mL). Then, the pH was adjusted to 14, and an aqueous layer was extracted from the mixture three times utilizing EtOAc (150 mL). The extracted organic layer was washed with brine (100 mL), dried over Na.sub.2SO.sub.4, and then concentrated. The obtained material was purified and separated by column chromatography utilizing silica gel utilizing CH.sub.2Cl.sub.2 and hexane as development solvents to thereby obtain Intermediate Compound 31-7 (yield of 49%).

4. Synthesis of Intermediate Compound 31-8

[0427] ##STR00131##

[0428] Intermediate Compound 31-7 (2.50 g, 5.77 mmol) and pyridine hydrochloride (3.95 g, 34.1 mmol) were heated at 200° C. for 6 hours. After adding water thereto, the mixture was subjected to an extraction process utilizing ethyl acetate, dried over Na.sub.2SO.sub.4, and then purified and separated by column chromatography utilizing silica gel utilizing CH.sub.2Cl.sub.2 and hexane as development solvents to thereby obtain Intermediate Compound 31-8 (1.31 g, yield of 52%).

5. Synthesis of Compound D31

[0429] ##STR00132##

[0430] Acetic acid (30 mL), Intermediate Compound 31-8 (1.06 g, 2.50 mmol), and Pt salt (1.15 g, 2.79 mmol) were added to a 250 mL round-bottom flask, degassed with nitrogen for 30 minutes, and then heated at 130° C. in an oil bath until Intermediate compound 31-8 was completely reacted (for about 4 days). After cooling, the mixture was mixed with heptane, and the mixed solution was stirred and filtered. The obtained solid was purified by silica gel column chromatography utilizing a mixed solvent including dichloromethane (DCM) and ethyl acetate (2% of ethyl acetate in DCM) to thereby obtain Compound D31 (423 mg, yield of 39.9%). The obtained compound was identified by liquid chromatography-mass spectroscopy (LC-MS) as Compound D31.

Preparation Example 1

[0431] As a substrate and an anode, a glass substrate with 15 Ω/cm.sup.2 (1,200 Å) ITO thereon (product of Corning Inc.) was cut to a size of 50 mm×50 mm×0.7 mm, sonicated utilizing isopropyl alcohol and pure water for 5 minutes each, and then washed by irradiation of ultraviolet rays and exposure of ozone thereto for 30 minutes. Then, the glass substrate was mounted on a vacuum deposition apparatus.

[0432] 2-TNATA was vacuum-deposited on an ITO anode on the glass substrate to form a hole injection layer having a thickness of 200 Å, and NPB was vacuum-deposited on the hole injection layer to form a hole transport layer having a thickness of 300 A.

[0433] CBP (host) and Compound D6 (dopant) were co-deposited at a weight ratio of 94:6 on the hole transport layer to form an emission layer having a thickness of 300 Å.

[0434] TPBi was deposited on the emission layer to form an electron transport layer having a thickness of 300 Å, LiF was deposited on the electron transport layer to form an electron injection layer having a thickness of 10 Å, and then, Al was vacuum-deposited on the electron injection layer to form a cathode having a thickness of 1,000 Å, thereby completing the manufacture of an organic light-emitting device.

##STR00133##

Preparation Examples 2 to 5 and Comparative Preparation Examples 1 to 5

[0435] Organic light-emitting devices were manufactured in substantially the same manner as in Preparation Example 1, except that compounds shown in Table 2 were respectively utilized instead of Compound D6 in forming respective emission layers.

Evaluation Example 2

[0436] The driving voltage, current density, efficiency, and lifespan of each of the organic light-emitting devices manufactured according to Preparation Examples 1 to 5 and Comparative Preparation Examples 1 to 5 were measured by utilizing Keithley SMU 236 and a luminance meter PR.sub.650, and the results are shown in Table 2. In this regard, the driving voltage and luminescence efficiency were measured based on the luminance of 1,000 cd/m.sup.2.

TABLE-US-00002 TABLE 2 Maximum Emission Dopant Driving luminescence Luminescence wave- com- voltage efficiency efficiency length pound (V) (cd/A) (cd/A) (nm) Preparation D6 3.1 47.94 47.93 579 Example 1 Preparation D13 3.1 47.93 47.92 541 Example 2 Preparation D22 3.1 47.89 47.87 565 Example 3 Preparation D27 2.9 46.96 46.94 662 Example 4 Preparation D49 2.9 46.94 46.92 722 Example 5 Comparative R2 3.8 29.67 19.58 541 Preparation Example 1 Comparative R3 3.6 12.17 12.09 517 Preparation Example 2 Comparative R6 3.6 39.07 37.19 593 Preparation Example 3 Comparative R7 3.6 38.64 36.65 594 Preparation Example 4 Comparative R8 3.6 32.97 29.34 616 Preparation Example 5 [00134][00135][00136][00137][00138][00139][00140][00141][00142][00143][00144][00145][00146]

[0437] From Table 2, it was confirmed that the organic light-emitting devices according to Preparation Examples 1 to 5 each had superior driving voltage and luminescence efficiency characteristics to those of the organic light-emitting devices according to Comparative Preparation Examples 1 to 5.

[0438] According to the one or more embodiments, the utilization of the organometallic compound may enable the manufacture of a light-emitting device having excellent or suitable efficiency characteristics and a high-quality electronic apparatus including the light-emitting device.

[0439] The use of “may” when describing embodiments of the present disclosure refers to “one or more embodiments of the present disclosure”.

[0440] As used herein, the terms “substantially”, “about”, and similar terms are used as terms of approximation and not as terms of degree, and are intended to account for the inherent deviations in measured or calculated values that would be recognized by those of ordinary skill in the art. “About” or “approximately,” as used herein, is inclusive of the stated value and means within an acceptable range of deviation for the particular value as determined by one of ordinary skill in the art, considering the measurement in question and the error associated with measurement of the particular quantity (i.e., the limitations of the measurement system). For example, “about” may mean within one or more standard deviations, or within ±30%, 20%, 10%, 5% of the stated value.

[0441] Any numerical range recited herein is intended to include all sub-ranges of the same numerical precision subsumed within the recited range. For example, a range of “1.0 to 10.0” is intended to include all subranges between (and including) the recited minimum value of 1.0 and the recited maximum value of 10.0, that is, having a minimum value equal to or greater than 1.0 and a maximum value equal to or less than 10.0, such as, for example, 2.4 to 7.6. Any maximum numerical limitation recited herein is intended to include all lower numerical limitations subsumed therein and any minimum numerical limitation recited in this specification is intended to include all higher numerical limitations subsumed therein. Accordingly, Applicant reserves the right to amend this specification, including the claims, to expressly recite any sub-range subsumed within the ranges expressly recited herein.

[0442] The electronic apparatus, the display device, and/or any other relevant devices or components according to embodiments of the present invention described herein may be implemented utilizing any suitable hardware, firmware (e.g. an application-specific integrated circuit), software, or a combination of software, firmware, and hardware. For example, the various components of the device may be formed on one integrated circuit (IC) chip or on separate IC chips. Further, the various components of the device may be implemented on a flexible printed circuit film, a tape carrier package (TCP), a printed circuit board (PCB), or formed on one substrate. Further, the various components of the device may be a process or thread, running on one or more processors, in one or more computing devices, executing computer program instructions and interacting with other system components for performing the various functionalities described herein. The computer program instructions are stored in a memory which may be implemented in a computing device using a standard memory device, such as, for example, a random access memory (RAM). The computer program instructions may also be stored in other non-transitory computer readable media such as, for example, a CD-ROM, flash drive, or the like. Also, a person of skill in the art should recognize that the functionality of various computing devices may be combined or integrated into a single computing device, or the functionality of a particular computing device may be distributed across one or more other computing devices without departing from the scope of the embodiments of the present disclosure.

[0443] It should be understood that embodiments described herein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as available for other similar features or aspects in other embodiments. While one or more embodiments have been described with reference to the drawings, it will be understood by those of ordinary skill in the art that one or more suitable changes in form and details may be made therein without departing from the spirit and scope as defined by the following claims and equivalents thereof.